Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

Search
Advanced Search
OPEN ACCESS
mobile search button mobile menu button

Articles

Page Path
HOME > Cancer Res Treat > Volume 53(2); 2021 > Article
Special Article Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2018
Seri Hong1,2, Young-Joo Won1,2,3, Jae Jun Lee1,2, Kyu-Won Jung1,2, Hyun-Joo Kong1,2, Jeong-Soo Im4, Hong Gwan Seo1,3, The Community of Population-Based Regional Cancer Registries
Cancer Research and Treatment : Official Journal of Korean Cancer Association 2021;53(2):301-315.
DOI: https://doi.org/10.4143/crt.2021.291
Published online: March 17, 2021

1Korea Central Cancer Registry, National Cancer Center, Goyang, Korea

2Division of Cancer Registration and Surveillance, National Cancer Control Institute, National Cancer Center, Goyang, Korea

3National Cancer Center Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea

4National Cancer Control Institute, National Cancer Center, Goyang, Korea

Correspondence: Young-Joo Won, Korea Central Cancer Registry, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang 10408, Korea,
Tel: 82-31-920-2015 Fax: 82-31-920-2179 E-mail: astra67@ncc.re.kr
* Regional Cancer Registry Committee Chang-Hoon Kim (Busan Cancer Registry, Pusan National University Hospital), Cheol-In Yoo (Ulsan Caner Registry, Ulsan University Hospital), Yong-Dae Kim (Chungbuk Cancer Registry, Chungbuk National University Hospital), Young-Taek Kim (Daejeon/Chungnam Cancer Registry, Chungnam National University and Hospital), Chul Min Park (Jeju Cancer Registry, Jeju National University and Hospital), Jung-Ho Youm (Chonbuk Cancer Registry, Jeonbuk National University Hospital), Kyuhyoung Lim (Kangwon Cancer Registry, Kangwon National University Hospital), Nam-Soo Hong (Daegu/Gyeongbuk Cancer Registry, Kyungpook National University Medical Center), Sun-Seog Kweon (Gwangju/Jeonnam Cancer Registry, Chonnam National University Hwasun Hospital), Woo-Chul Kim (Incheon Cancer Registry, Inha University Hospital), Ki-Soo Park (Gyeongnam Cancer Registry, Gyeongsang National University and Hospital).
• Received: March 7, 2021   • Accepted: March 16, 2021

Copyright © 2021 by the Korean Cancer Association

This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 22,280 Views
  • 913 Download
  • 231 Web of Science
  • 244 Crossref
  • 239 Scopus
prev next
Full Article

Download PDF Download PDF

  • Purpose
    The current study provides national cancer statistics and their secular trends in Korea, including incidence, mortality, survival, and prevalence in 2018.
  • Materials and Methods
    Incidence, survival, and prevalence rates of cancer were calculated using the Korea National Cancer Incidence Database, from 1999 to 2018, with survival follow-up until December 31, 2019. Deaths from cancer were assessed using causes-of-death data obtained from Statistics Korea. Crude and age-standardized rates (ASRs) for incidence, mortality, prevalence, and 5-year relative survival rates were calculated, and temporal trends for incidence and mortality rates were evaluated, with annual percentage changes.
  • Results
    In 2018, newly diagnosed cancer cases and deaths from cancer were reported as 243,837 (ASR, 270.4 per 100,000) and 79,153 (ASR, 73.3 per 100,000), respectively. The overall cancer incidence rates increased by 3.3% annually from 1999 to 2012, and decreased by 5.4% annually from 2012 to 2015, thereafter, followed by nonsignificant changes. Cancer mortality rates have been decreasing since 2002, with more rapid decline in recent years (annual decrease of 2.7% from 2007 to 2014; 3.7% from 2014 to 2018). The 5-year relative survival between 2014 and 2018 was 70.3%, which contributed to prevalent cases reaching over 2 million by the end of 2018.
  • Conclusion
    Cancer statistics have improved significantly during the past two decades. However, there remain important challenges to be solved, such as controlling cancers with low survival rates. Cancer statistics can be used to discover blind spots in cancer control, and as evidence for developing and implementing future cancer control strategies.
  • Key words: Neoplasms, Incidence, Mortality, Survival, Prevalence, Korea
It is estimated that cancer affects one in five men or women, and causes one in six deaths worldwide, according to the recent reports on global cancer statistics [1,2]. To address the overwhelming disease burden of cancer, collecting data and producing cancer statistics are the initial and fundamental steps indispensable to each nation’s cancer control plan. In this regard, Korea has been compiling the national cancer registry data and publishing its statistics for more than 20 years. The current study reports the most recent nationwide statistics on cancer incidence, survival, prevalence, and mortality, and their temporal trends.
1. Data sources
Annual cancer statistics in Korea are calculated using a national and population-based database of cancer occurrence, the Korea National Cancer Incidence Database (KNCI DB). Every year, the Korea Central Cancer Registry (KCCR) collects information on patients diagnosed with cancer, in any hospital across the country during the past year, and backs up the data from the year before the last, with data compiled by central and 11 regional cancer registries that also include information regarding missing cancer patients. Hence, it takes two years to complete and calculate the year’s KNCI DB and cancer statistics. The KCCR has reported such nationwide statistics from 1999 onward; other detailed information on the KCCR and KNCI DB is provided elsewhere [3]. Completeness is an important indicator of data quality, and the 2018 KNCI DB was estimated to be 98.2% complete using the method proposed by Ajiki et al. [4].
Annual mid-year population data and recently updated mortality data including causes of death from 1983 were obtained from Statistics Korea [5]. To confirm the validity of individual vital statuses used in survival and prevalence calculation, the KNCI DB was linked to both mortality and population resident registration data, which were obtained from the Ministry of the Interior and Safety.
2. Cancer classification
All cancer cases had been registered in accordance with the International Classification of Diseases for Oncology, 3rd edition (ICD-O-3) [6]. The range of cancers to be registered and used for the national statistics calculation was limited to records with a behavior code of “/2 (carcinoma in situ)” or “/3 (malignant),” from the morphology (i.e., histology) codes of ICD-O-3, by which a patient was initially enrolled in the KNCI DB. Similar to previous reports, malignant cancer cases and their statistics were mainly assessed in this article. In addition, the supplementary incidence statistics for carcinoma in situ cases were also calculated separately, using 2018 KNCI DB.
For the convenience of classification and reporting, the ICD-O-3 codes were converted to the classification of the International Classification of Diseases, 10th edition (ICD-10) [7]. Exceptionally, some hematopoietic diseases (myeloproliferative disorders/myelodysplastic syndromes) are not classified as malignant cancer in ICD-10 classification, therefore their ICD-O-3 codes were used without any conversion. For mortality data, causes of death were coded according to the ICD-10.
We adopted cancer classifications with 24 and 61 types; the former was a modified classification based on the GLOBOCAN cancer dictionary [8], and the latter was the taxonomy used in “Cancer Incidence in Five Continents” [9], and both of them were provided by the International Association of Cancer Registries. In this article, cancer classification with 24 types of cancer was used for description. The summary staging system developed under the Surveillance, Epidemiology, and End Results (SEER) program (i.e., SEER summary staging) [10] was used to categorize the extent of tumor invasion or metastasis.
3. Statistical analyses
Incidence, mortality, and prevalence rates were expressed as crude rates (CRs) or age-standardized rates (ASRs) per 100,000 people. The CR was defined as the total number of newly diagnosed (for incidence) or deceased (for mortality) cases in a year divided by the mid-year population. The ASR was defined as the weighted average of the age-specific rates in which the weights represent the proportions of people in the corresponding age groups in a standard population [11]. ASRs were standardized using Segi’s world standard population [12]. The cumulative risk of developing cancer from birth to life expectancy during 2018 in Korea were also assessed, assuming no other cause of death (i.e., by simply calculating the sum of the age-specific cancer rates from birth to life expectancy), as follows [11]:
Cumulative risk of developing cancer from birth to like expectancy=100×(1-e-cumulative rate100)
Trends in ASRs were estimated using Joinpoint regression [13], with a maximum number of two joinpoints. The results were summarized as annual percentage changes with the best model fit, based on a linear model for the natural log-transformed ASRs.
The survival rate of cancer patients, diagnosed between 1993 and 2018, was calculated based on the results of follow-up until December 31, 2019. The 5-year relative survival rate was defined as the ratio of observed survival of cancer patients to expected survival in the general population, adjusting the effects of other causes of death using the standard population life table provided by Statistics Korea [5]. Relative survival rates were estimated using the Ederer II method [14] with some minor corrections, based on an algorithm devised by Paul Dickman [15]. Trends in 5-year relative survival rates were evaluated as percent differences in survival rates between 1993–1995 and 2014–2018.
Prevalent cases were defined as the number of cancer patients alive on January 1, 2019 among all the patients diagnosed with cancer between 1999 and 2018. Limited-duration prevalence was calculated using SEER*Stat 8.3.8 software (National Cancer Institute, Bethesda, MD). p < 0.05 was considered statistically significant. SEER*Stat, Joinpoint 4.8.0 (National Cancer Institute), and SAS ver. 9.4 (SAS Institute, Cary, NC) were used for statistical analyses.
1. Incidence
In 2018, a total of 243,837 people were newly diagnosed with cancer in Korea, of which 52.8% (128,757 cases) were men and 47.2% (115,080 cases) were women (Table 1). Five most diagnosed cancers in Korea were stomach, thyroid, lung, colorectal, and breast cancers; in men, stomach and lung cancers were followed by colorectal, prostate, and liver cancers, whereas breast and thyroid cancers were followed by colorectal, stomach, and lung cancers in women. These top five cancers in each sex accounted for 64.2% and 65.4% of all cancer cases in men and women, respectively. Table 2 provides the CRs and ASRs of cancer incidence in 2018. The CR and ASR of all cancer incidence were 475.3 per 100,000 (502.9 for men and 447.8 for women) and 270.4 per 100,000 (295.2 for men and 259.4 for women), respectively. Such differences between CR and ASR, revealed in values and their relative ranks, imply that majority of cancer patients in Korea belong to the old age group (because the world’s standard population consists of a higher proportion of young people) and there are differences in the age composition of patients according to the site of cancer. The overall lifetime probability of being diagnosed with any cancer was 37.4%, under the condition that one survives to the age that matches the life expectancy of the Korean population. That probability was higher in men (39.8%) than in women (34.2%) (data not shown).
There were marked differences in major cancers of each age-specific group (Fig. 1). In the childhood population (0–14 years), leukemia, non-Hodgkin lymphoma, and brain and central nervous system (CNS) cancer were the top three cancers in both sexes, accounting for 30.5%, 16.1%, and 14.2% of all cancer cases diagnosed in this age group, respectively. Thyroid cancer was the most common cancer in both sexes among the adolescent and young adult population (15–34 years), with a proportion of 50.8% of all cancers diagnosed. Leukemia and non-Hodgkin lymphoma were ranked next in men, while breast and cervix cancers were the next highest in women among that age group. In the 35–64-year age group population, men were most commonly diagnosed with stomach, colorectal, liver, and lung cancers (collectively accounting for 54.1%), while breast and thyroid cancers were most common in women (collectively accounting for 54.4%). For those aged 65 years and above, lung and prostate cancers were most common in men, while colorectal and lung cancers were most common in women. Most cancers demonstrated higher incidence rates in older age groups (i.e., incidence rates increased with age); the only exceptions were thyroid cancer in both sexes and breast cancer in women, which showed the highest incidences among the 30–40s and 40–50s age groups, respectively (Fig. 2).
2. Mortality
Since the causes-of-death statistics began to be reported in 1983, cancer has been the first cause of death in Korea. In 2018, a total of 79,153 people (61.8% men and 38.2% women) died of cancer, accounting for 26.5% of all deaths occurring in Korea (Tables 1 and 3). The overall CR for cancer deaths was 154.3 per 100,000, and the rate in men was approximately 1.6 times higher than in women (Table 4). Lung cancer was the leading cause of cancer death in both sexes (CR, 51.5 per 100,000 in men and 18.1 per 100,000 in women), followed by liver and stomach cancers in men, and colorectal and pancreatic cancers in women. When stratified according to the age at the time of death, the most common causes of cancer mortality were as follows: leukemia at ages 10 and 20 years, stomach cancer at 30 years, liver cancer at 40 and 50 years, and lung cancer at 60 years or more (data not shown).
3. Trends in cancer incidence and mortality
Changes in cancer incidence rates from 1999 to 2018 and mortality rates from 1983 to 2018 are depicted in Fig. 3. Compared to 1999, cancer incidence rates increased about 27.5% and mortality rates decreased about 35.9%, in 2018 (Table 5). The overall cancer incidence rates increased by approximately 3.3% per year until 2012, followed by a decline until 2015 with an annual decrease of 5.4%, and thereafter showed nonsignificant changes. In contrast, cancer mortality rates demonstrated nonsignificant changes until 2002, and decreased thereafter with an annual decrease of 2.7% until 2014, and a further decrease of 3.7% per year until 2018. These trends were observed similarly in both men and women, although the slopes of change were much more pronounced in women for incidence, and in men for mortality rates (S1 and S2 Tables).
Since 1999, breast, pancreas, kidney, and hematologic (leukemia and lymphoma) cancers, and that of some male or female reproductive organs (ovary, corpus uteri, prostate, and testis) have been continuously increasing. In both sexes combined, breast (especially for women) and kidney cancers displayed initial rapid increases and then lessened increases after 2007 and 2009, respectively. Prostate cancer demonstrated distinguished increase until 2009, followed by nonsignificant trend until 2015, and regained increasing trend thereafter. The remaining cancers with increasing trend revealed steady increases throughout the entire period. On the other hand, the incidences of colorectal, thyroid, and bladder cancers demonstrated increasing trends that have recently reversed significantly, with decreases starting in 2011, 2011, and 2004, respectively. Finally, in contrast, stomach and liver cancers demonstrated initial moderate decreasing trends until 2011 and 2010, respectively, followed by more rapid decreases thereafter; and cervical cancer showed initial nonsignificant trend until 2001, followed by marked decrease until 2007, however it showed lessened decrease thereafter until now (Table 5). These trends were observed similarly in both men and women, except for breast and thyroid cancer incidences in men and colorectal and bladder cancer incidences in women that revealed partially different results of trends from those described above (Fig. 4, S1 and S2 Tables).
Recently, the ASRs for mortality in most cancers have shown decreasing trends in Korea. Stomach cancer revealed continuous decreasing trends throughout the entire observed period for mortality, with more pronounced decreasing slopes in more recent periods. On the other hand, the mortality rates of colorectal, cervical, and thyroid cancers initially increased (significantly, for colorectal and cervical cancers; nonsignificantly, for thyroid cancer) until 2003, and began to decline thereafter (for cervical and thyroid cancers) or after a nonsignificant period of 10 years from 2003 had passed (i.e., from 2012, for colorectal cancer). Liver and lung cancer mortality rates began to decrease in 2002 and 2001, respectively, after nonsignificant trends until those years, followed by further rapid decreases starting in 2014 (Table 5). These trends were observed similarly in both sexes. In contrast, breast cancer (women) displayed significantly increasing mortality trends until 2016, followed by nonsignificant changes thereafter (Fig. 5, S1 and S2 Tables).
4. Survival rates
Over the past two decades, when cancer survival statistics have been compiled, the relative survival rates of cancer patients have increased significantly and steadily. The 5-year relative survival rates for all patients diagnosed with cancer in the recent five years, from 2014 to 2018 were 63.8% in men and 77.1% in women, for a combined overall survival rate of 70.3% (Table 6). The temporal increasing trends in survival rates, from 42.9% in 1993–1995 to 70.3% in 2014–2018, were maintained even after excluding thyroid cancer (from 41.2% in 1993–1995 to 65.7% in 2014–2018), which has excellent prognosis and a 5-year relative survival rate of 100%.
After thyroid cancer, survival was the highest for testis and prostate cancers in men (95.1% and 94.4%, respectively) and breast cancer in women (93.3%); survival was lowest for cancers of the pancreas (12.6%), and gallbladder plus other and unspecified parts of the biliary tract (28.8%). Stomach cancer (both sexes), prostate cancer (men), lung cancer, and leukemia (women) were associated with outstanding improvements in survival rates over the time period studied. In contrast, advances have been slow for cancers of the brain and CNS, pancreas (both sexes), and bladder (women).
In terms of stage distribution at diagnosis and recent survival rates according to the SEER summary stage in each cancer, Fig. 6 shows the top 10 most common cancers for each sex in 2018. In men, stomach, kidney, and bladder cancers revealed the highest proportions of patients who were diagnosed at the localized stage (64.3%, 71.7%, and 72.5%, respectively), accompanied by the 5-year survival rates of 97.4%, 98.0%, and 87.6%, respectively. In contrast, lung and pancreatic cancers demonstrated the highest proportions of patients diagnosed at the distant metastatic stage (i.e., the lowest proportions of localized stage), which approximated to 50%, with corresponding 5-year survival rates of 7.0% and 1.9%, respectively. In women, 58.4%, 62.9%, and 72.3% of breast, stomach, and uterine corpus cancers, respectively, were diagnosed at the localized stage, with 5-year survival rates of 98.8%, 95.7%, and 96.1%, respectively. However, more than 40% of lung and pancreatic cancers were diagnosed at the distant metastatic stage, with 5-year survival rates of 13.4% and 1.9%, respectively.
5. Prevalence rates
The total prevalent cancer cases in 2018 (identified as survivor at the time of January 1, 2019) were 2,005,520, surpassing 2 million for the first time in Korea (Table 1). It suggested that 1 in 25 people (3.9% of the entire Korean population; 3.4% of men and 4.4% of women) has a history of being diagnosed with cancer. Of these, 906,204 (45.2% of all prevalent cases) were aged ≥ 65 years, indicating that 1 in 8 people in that age group (15.8% of, or 1 in 6, men and 9.7% of, or 1 in 10, women) would have experienced cancer (data not shown).
Table 7 provides the CRs and ASRs of prevalence for all cancers combined and for specific cancers. In total, the cancer prevalence rate for 2018 in Korea was 3,909.3 per 100,000 people. Thyroid cancer had the highest prevalence (CR, 843.9 per 100,000; 302.5 per 100,000 for men and 1,383.3 per 100,000 for women), followed by stomach cancer (CR, 593.1 per 100,000) and colorectal cancer (CR, 517.1 per 100,000). Prostate cancer (men) and breast cancer (women) also revealed high prevalence rates (CR, 378.3 and 921.8 per 100,000, respectively).
The number of prevalent cases for common cancers, according to the time since cancer diagnosis, are described in Fig. 7. In total, 1,160,147 (57.8% of all prevalent cases) had survived > 5 years after cancer diagnosis, including many survivors of thyroid, stomach, colorectal, and breast cancers. Another 448,263 (22.4% of all prevalent cases) have been alive 2–5 years after their cancer diagnosis, in which period they need regular follow-up; and the rest were 397,110 (19.8% of all prevalent cases) for whom it had been < 2 years since their cancer diagnosis, in which period they still need active cancer treatment.
6. Carcinoma in situ incidence
A summary of carcinoma in situ cases in 2018 is provided as a Supplementary Material (S3 Material, S4 and S7 Tables, S5, S6, and S8 Figs.).
During the past two decades, regardless of the increases in cancer incidence due to changes in biologic, behavioral, and environmental risk factors, overall cancer statistics have improved significantly as a result of national cancer control plans that have been carried out throughout the years. Incidence and mortality rates for major cancers in Korea, i.e., stomach, colorectal, liver, breast, uterine cervix, and lung, have been exhibiting decreasing trends currently, except for increasing incidences in women for breast and lung cancers. The 5-year relative survival rates have continuously improved, reaching over 70% for all patients diagnosed with cancer in recent years. Cancer prevalence in Korea has rapidly increased due to such remarkable improvements in cancer survival, reaching over 2 million by the end of 2018. Despite those advances, there remain important challenges to be solved, such as the stagnant decreasing trend of cancer incidence rates in recent years, and treatment of cancers with low survival rates, including rare cancers. Cancer statistics can be used to discover blind spots in cancer control, and as evidence for comprehensive and precise cancer control strategies that need to be continuously developed and implemented.
Supplementary materials are available at Cancer Research and Treatment website (https://www.e-crt.org).
crt-2021-291_S1Table.pdf
crt-2021-291_S2Table.pdf
crt-2021-291_S3Material.pdf
crt-2021-291_S4Table.pdf
crt-2021-291_S5Fig.pdf
crt-2021-291_S6Fig.pdf
crt-2021-291_S7Table.pdf
crt-2021-291_S8Fig.pdf

Author Contributions

Conceived and designed the analysis: Won YJ.

Collected the data: Won YJ, Regional Cancer Registry Committee.

Contributed data or analysis tools: Hong S, Won YJ, Jung KW, Kong HJ.

Performed the analysis: Lee JJ.

Wrote the paper: Hong S, Won YJ.

Interpretation and review: Jung KW, Kong HJ.

Review and comment: Im JS, Seo HG.

Conflicts of Interest

Conflict of interest relevant to this article was not reported.

Acknowledgements
Special thanks to the tumor registrars (health information managers) of the Korea Central Cancer Registry (KCCR)-affiliated and non-KCCR-affiliated hospitals for data collection, abstracting, and coding. Additionally, we acknowledge the cooperation of the National Health Insurance Service and Statistics Korea for data support. This work was supported by the Health Promotion Fund of the Ministry of Health & Welfare (No. 2060570) and a research grant (No. 1910130) from the National Cancer Center, Republic of Korea.
Fig. 1
The five common sites of cancer incidence by age group and sex in Korea, 2018. (A) Men. (B) Women. Numbers in the graph are age-specific incidence rates per 100,000. CNS, central nervous system.
crt-2021-291f1.jpg
Fig. 2
Age-specific incidence rates of common cancers for 2018 in Korea. (A) Men. (B) Women.
crt-2021-291f2.jpg
Fig. 3
Annual age-standardized cancer incidence and mortality rates by sex for all sites from 1983 to 2018 in Korea. Age standardization was based on Segi’s world standard population.
crt-2021-291f3.jpg
Fig. 4
Trends in age-standardized incidences of selected cancers by sex from 1999 to 2018 in Korea. (A) Men. (B) Women. Age standardization was based on Segi’s world standard population.
crt-2021-291f4.jpg
Fig. 5
Trends in age-standardized mortalities of selected cancers by sex from 1983 to 2018 in Korea. (A) Men. (B) Women. Age standardization was based on Segi’s world standard population. a)Cancers of cervix uteri, corpus uteri, and unspecified parts of the uterus were combined (C53–C55), due to their unclear classifications in the past.
crt-2021-291f5.jpg
Fig. 6
Five-year relative survival rates by stage at diagnosis and stage distribution of selected cancers by sex in Korea, 2014–2018. (A) Men. (B) Women. Staging according to the Surveillance, Epidemiology, and End Results (SEER) stage categories. For each cancer type, stage categories do not total 100% because sufficient information was not available to stage all cases. a)Includes the gallbladder and other/unspecified parts of the biliary tract.
crt-2021-291f6.jpg
Fig. 7
Prevalent cases of common cancers by time since cancer diagnosis. Prevalent cases were defined as the number of cancer patients alive on January 1, 2019 among all cancer patients diagnosed between 1999 and 2018.
crt-2021-291f7.jpg
Table 1
Cancer incidence, mortality, and prevalence by sex in Korea, 2018
Site/Type New cases Deaths Prevalent casesa)
Both sexes Men Women Both sexes Men Women Both sexes Men Women
All sites 243,837 128,757 115,080 79,153 48,898 30,255 2,005,520 881,057 1,124,463
Lip, oral cavity, and pharynx 3,806 2,740 1,066 1,137 841 296 27,533 18,422 9,111
Esophagus 2,698 2,449 249 1,435 1,314 121 11,238 10,055 1,183
Stomach 29,279 19,865 9,414 7,746 5,083 2,663 304,265 201,278 102,987
Colon and rectum 27,909 16,686 11,223 8,715 4,900 3,815 265,291 157,777 107,514
Liverb) 15,736 11,728 4,008 10,611 7,790 2,821 71,774 53,903 17,871
Gallbladderc) 7,179 3,840 3,339 4,871 2,504 2,367 24,013 12,408 11,605
Pancreas 7,611 4,020 3,591 6,036 3,193 2,843 13,321 6,926 6,395
Larynx 1,143 1,081 62 295 271 24 11,461 10,787 674
Lungd) 28,628 19,524 9,104 17,852 13,188 4,664 93,600 56,954 36,646
Breast 23,647 100 23,547 2,473 13 2,460 237,771 867 236,904
Cervix uteri 3,500 - 3,500 845 - 845 57,104 - 57,104
Corpus uteri 3,182 - 3,182 327 - 327 28,249 - 28,249
Ovary 2,898 - 2,898 1,243 - 1,243 22,641 - 22,641
Prostate 14,857 14,857 - 1,995 1,995 - 96,852 96,852 -
Testis 335 335 - 17 17 - 3,747 3,747 -
Kidney 5,456 3,806 1,650 989 672 317 46,358 31,302 15,056
Bladder 4,577 3,650 927 1,400 1,055 345 37,722 30,734 6,988
Brain and CNS 2,024 1,088 936 1,355 727 628 12,356 6,332 6,024
Thyroid 28,651 6,727 21,924 372 109 263 432,932 77,440 355,492
Hodgkin lymphoma 299 181 118 62 39 23 3,215 1,988 1,227
Non-Hodgkin lymphoma 5,216 3,001 2,215 1,876 1,075 801 35,224 19,993 15,231
Multiple myeloma 1,719 927 792 953 508 445 7,008 3,677 3,331
Leukemia 3,494 2,037 1,457 1,848 1,081 767 23,782 13,250 10,532
Other and ill-defined 19,993 10,115 9,878 4,700 2,523 2,177 138,063 66,365 71,698

CNS, central nervous system.

a) Limited-duration prevalent cases on January 1, 2018. These are patients who were diagnosed between January 1, 1999 and December 31, 2018, and who were alive on January 1, 2019. Multiple primary cancer cases were counted multiple times,

b) Includes the liver and intrahepatic bile duct,

c) Includes the gallbladder and other/unspecified parts of the biliary tract,

d) Includes the lung and bronchus.

Table 2
Crude and age-standardized cancer incidence rates by sex in Korea, 2018
Site/Type Crude incidence rates per 100,000 Age-standardized incidence rates per 100,000a)
Both sexes Men Women Both sexes Men Women
All sites 475.3 502.9 447.8 270.4 295.2 259.4
Lip, oral cavity, and pharynx 7.4 10.7 4.1 4.3 6.3 2.4
Esophagus 5.3 9.6 1.0 2.7 5.4 0.5
Stomach 57.1 77.6 36.6 30.4 44.3 18.3
Colon and rectum 54.4 65.2 43.7 28.4 37.4 20.6
Liverb) 30.7 45.8 15.6 16.2 26.3 7.2
Gallbladderc) 14.0 15.0 13.0 6.6 8.2 5.2
Pancreas 14.8 15.7 14.0 7.4 8.8 6.3
Larynx 2.2 4.2 0.2 1.2 2.4 0.1
Lungd) 55.8 76.3 35.4 27.6 41.9 16.4
Breast 46.1 0.4 91.6 29.1 0.2 57.9
Cervix uteri 6.8 - 13.6 4.4 - 8.8
Corpus uteri 6.2 - 12.4 3.9 - 7.7
Ovary 5.6 - 11.3 3.6 - 7.1
Prostate 29.0 58.0 - 14.3 31.9 -
Testis 0.7 1.3 - 0.7 1.3 -
Kidney 10.6 14.9 6.4 6.3 9.2 3.6
Bladder 8.9 14.3 3.6 4.3 7.9 1.5
Brain and CNS 3.9 4.2 3.6 3.0 3.3 2.7
Thyroid 55.8 26.3 85.3 40.2 18.8 62.2
Hodgkin lymphoma 0.6 0.7 0.5 0.5 0.6 0.4
Non-Hodgkin lymphoma 10.2 11.7 8.6 6.5 8.0 5.0
Multiple myeloma 3.4 3.6 3.1 1.7 2.0 1.4
Leukemia 6.8 8.0 5.7 5.3 6.4 4.4
Other and ill-defined 39.0 39.5 38.4 21.9 24.5 19.7

CNS, central nervous system.

a) Age-adjusted using Segi’s world standard population,

b) Includes the liver and intrahepatic bile duct,

c) Includes the gallbladder and other/unspecified parts of the biliary tract,

d) Includes the lung and bronchus.

Table 3
The top 10 leading causes of death in Korea, 2018
Rank Cause of death No. of deaths Percentage of all deaths Age-standardized death rate per 100,000a)
All causes 298,777 100.0 268.3
1 Cancer 79,153 26.5 73.3
2 Heart disease 32,004 10.7 26.5
3 Cerebrovascular disease 22,940 7.7 18.7
4 Pneumonia 23,280 7.8 17.5
5 Intentional self-harm (suicide) 13,670 4.6 18.2
6 Diabetes mellitus 8,789 2.9 7.3
7 Disease of liver 6,858 2.3 7.4
8 Chronic lower respiratory diseases 6,608 2.2 5.0
9 Hypertensive diseases 6,065 2.0 4.5
10 Transport accidents 4,671 1.6 5.7
Others 94,782 31.7 84.3

Source: Mortality data, 2018, Statistics Korea [5].

a) Age-adjusted using Segi’s world standard population.

Table 4
Crude and age-standardized cancer mortality rates by sex in Korea, 2018
Site/Type Crude mortality rates per 100,000 Age-standardized mortality rates per 100,000a)
Both sexes Men Women Both sexes Men Women
All sites 154.3 191.0 117.7 73.3 105.3 49.5
Lip, oral cavity, and pharynx 2.2 3.3 1.2 1.1 1.8 0.5
Esophagus 2.8 5.1 0.5 1.3 2.8 0.2
Stomach 15.1 19.9 10.4 7.1 11.0 4.1
Colon and rectum 17.0 19.1 14.8 7.7 10.6 5.5
Liverb) 20.7 30.4 11.0 10.2 17.0 4.4
Gallbladderc) 9.5 9.8 9.2 4.2 5.2 3.4
Pancreas 11.8 12.5 11.1 5.5 6.9 4.3
Larynx 0.6 1.1 0.1 0.3 0.6 0.0
Lungd) 34.8 51.5 18.1 15.7 27.5 7.0
Breast 4.8 0.1 9.6 2.7 0.0 5.3
Cervix uteri 1.6 - 3.3 0.9 - 1.7
Corpus uteri 0.6 - 1.3 0.3 - 0.6
Ovary 2.4 - 4.8 1.3 - 2.4
Prostate 3.9 7.8 - 1.5 4.2 -
Testis 0.0 0.1 - 0.0 0.1 -
Kidney 1.9 2.6 1.2 0.9 1.5 0.5
Bladder 2.7 4.1 1.3 1.1 2.2 0.4
Brain and CNS 2.6 2.8 2.4 1.7 1.9 1.5
Thyroid 0.7 0.4 1.0 0.3 0.2 0.4
Hodgkin lymphoma 0.1 0.2 0.1 0.1 0.1 0.0
Non-Hodgkin lymphoma 3.7 4.2 3.1 1.8 2.4 1.3
Multiple myeloma 1.9 2.0 1.7 0.8 1.1 0.7
Leukemia 3.6 4.2 3.0 2.1 2.7 1.7
Other and ill-defined 9.2 9.9 8.5 4.5 5.7 3.6

CNS, central nervous system.

a) Age-adjusted using Segi’s world standard population,

b) Includes the liver and intrahepatic bile duct,

c) Includes the gallbladder and other/unspecified parts of the biliary tract,

d) Includes the lung and bronchus.

Table 5
Trends in cancer incidence and mortality rates from 1999 to 2018 in Korea, both sexes
Site/Type Incidence Mortality
1999 2018 Trend 1 Trend 2 Trend 3 1999 2018 Trend 1 Trend 2 Trend 3
Years APC Years APC Years APC Years APC Years APC Years APC
All sites 212.0 270.4 1999–2012 3.3a) 2012–2015 −5.4a) 2015–2018 1.0 114.3 73.3 1999–2002 1.0 2002–2014 −2.7a) 2014–2018 −3.7a)
Lip, oral cavity, and pharynx 3.6 4.3 1999–2018 0.7a) - - - - 1.1 1.1 1999–2018 −1.9a) - - - -
Esophagus 4.1 2.7 1999–2018 −2.2a) - - - - 3.1 1.3 1999–2018 −4.4a) - - - -
Stomach 43.6 30.4 1999–2011 −0.2 2011–2018 −4.6a) - - 23.8 7.1 1999–2002 −2.6a) 2002–2010 −6.2a) 2010–2018 −7.4a)
Colon and rectum 20.6 28.4 1999–2006 7.2a) 2006–2011 3.1a) 2011–2018 −4.4a) 7.7 7.7 1999–2003 6.4a) 2003–2012 −0.4 2012–2018 −3.8a)
Liverb) 27.9 16.2 1999–2010 −1.7a) 2010–2018 −4.3a) - - 20.4 10.2 1999–2002 0.7 2002–2014 −3.6a) 2014–2018 −6.4a)
Gallbladderc) 6.5 6.6 1999–2004 1.4 2004–2018 −0.3a) - - 5.2 4.2 1999–2001 7.6 2001–2014 −2.8a) 2014–2018 0.5
Pancreas 5.6 7.4 1999–2018 1.5a) - - - - 5.4 5.5 1999–2018 0.2 - - - -
Larynx 2.4 1.2 1999–2018 −3.6a) - - - - 1.6 0.3 1999–2005 −8.0a) 2005–2008 −15.4a) 2008–2018 −7.1a)
Lungd) 28.5 27.6 1999–2011 0.1 2011–2015 −1.4a) 2015–2018 0.7 22.4 15.7 1999–2001 3.7 2001–2014 −1.9a) 2014–2018 −4.3a)
Breast 11.0 29.1 1999–2007 6.4a) 2007–2018 4.4a) - - 2.2 2.7 1999–2016 1.4a) 2016–2018 −2.7 - -
Cervix uteri 8.6 4.4 1999–2001 −1.0 2001–2007 −5.4a) 2007–2018 −2.8a) 1.4 0.9 1999–2003 10.0a) 2003–2008 −7.0a) 2008–2018 −4.2a)
Corpus uteri 1.4 3.9 1999–2018 5.1a) - - - - 0.1 0.3 1999–2003 35.9a) 2003–2018 2.4a) - -
Ovary 2.7 3.6 1999–2018 1.7a) - - - - 0.9 1.3 1999–2018 0.7a) - - - -
Prostate 3.1 14.3 1999–2009 14.9a) 2009–2015 0.6 2015–2018 6.8a) 0.9 1.5 1999–2002 15.0a) 2002–2011 1.7a) 2011–2018 −1.5a)
Testis 0.3 0.7 1999–2018 4.8a) - - - - 0.0 0.0 1999–2018 −2.4a) - - - -
Kidney 3.0 6.3 1999–2009 6.4a) 2009–2018 2.0a) - - 1.1 0.9 1999–2018 −0.4 - - - -
Bladder 4.7 4.3 1999–2004 1.9a) 2004–2018 −1.1a) - - 1.3 1.1 1999–2001 10.5 2001–2018 −1.9a) - -
Brain and CNS 2.9 3.0 1999–2018 0.2 - - - - 1.9 1.7 1999–2002 6.3a) 2002–2008 −3.5a) 2008–2018 −0.9a)
Thyroid 6.5 40.2 1999–2011 21.7a) 2011–2018 −9.3a) - - 0.4 0.3 1999–2003 7.5a) 2003–2018 −4.5a) - -
Hodgkin lymphoma 0.3 0.5 1999–2018 3.6a) - - - - 0.0 0.1 1999–2004 23.0a) 2004–2018 −1.7 - -
Non-Hodgkin lymphoma 4.3 6.5 1999–2018 2.3a) - - - - 2.1 1.8 1999–2018 −1.0a) - - - -
Multiple myeloma 1.0 1.7 1999–2012 3.7a) 2012–2018 1.0 - - 0.6 0.8 1999–2003 12.6a) 2003–2016 1.0 2016–2018 −7.6
Leukemia 4.7 5.3 1999–2018 0.9a) - - - - 2.9 2.1 1999–2018 −1.8a) - - - -
Other and ill-defined 15.0 21.9 1999–2001 −0.9 2001–2007 3.6a) 2007–2018 1.8a) 7.8 4.5 1999–2018 −2.8a) - - - -

APC was calculated using age-standardized incidence data based on Segi’s world standard population. APC, annual percentage change; CNS, central nervous system.

a) Significantly different from zero (p < 0.05),

b) Includes the liver and intrahepatic bile duct,

c) Includes the gallbladder and other/unspecified parts of the biliary tract,

d) Includes the lung and bronchus.

Table 6
Trends in the 5-year relative survival rates (%) by sex and year of diagnosis from 1993 to 2018 in Korea
Site/Type Both sexes Men Women
1993–1995 1996–2000 2001–2005 2006–2010 2011–2015 2014–2018 Changea) 1993–1995 1996–2000 2001–2005 2006–2010 2011–2015 2014–2018 Changea) 1993–1995 1996–2000 2001–2005 2006–2010 2011–2015 2014–2018 Changea)
All sites 42.9 45.1 54.1 65.5 70.7 70.3 27.4 33.2 36.3 45.6 56.8 63.1 63.8 30.6 55.1 56.4 64.3 74.4 78.3 77.1 22.0
All sites excluding thyroid 41.2 43.3 50.8 59.0 64.2 65.7 24.5 32.7 35.8 44.7 54.6 60.3 61.6 28.9 52.6 53.5 59.1 65.0 69.3 70.8 18.2
Lip, oral cavity, and pharynx 42.2 47.4 54.5 61.1 65.4 68.0 25.8 36.6 41.7 49.6 56.9 61.8 65.0 28.4 59.4 64.5 68.1 72.1 74.5 75.4 16.0
Esophagus 14.0 15.7 21.5 30.0 36.6 39.5 25.5 13.0 14.8 20.8 29.3 36.2 38.9 25.9 25.0 25.9 29.8 37.2 40.1 44.9 19.9
Stomach 43.8 47.3 58.0 68.4 75.9 77.0 33.2 43.9 47.6 58.7 69.1 76.8 77.8 33.9 43.7 46.8 56.6 67.0 74.0 75.2 31.5
Colon and rectum 56.2 58.8 66.9 73.9 76.1 74.3 18.1 56.6 59.8 68.8 75.8 77.8 75.6 19.0 55.7 57.7 64.5 71.1 73.6 72.3 16.6
Liverb) 11.8 14.1 20.5 28.3 34.4 37.0 25.2 10.8 13.8 20.4 28.2 34.9 37.8 27.0 15.0 15.1 20.9 28.3 32.8 34.7 19.7
Gallbladderc) 18.7 20.7 23.1 26.9 28.7 28.8 10.1 18.0 21.1 23.4 27.8 29.4 29.8 11.8 19.3 20.3 22.7 26.0 28.0 27.8 8.5
Pancreas 10.6 8.7 8.4 8.5 10.8 12.6 2.0 10.0 8.3 8.4 8.3 10.2 11.9 1.9 11.5 9.2 8.4 8.8 11.4 13.2 1.7
Larynx 61.6 63.3 66.5 73.2 75.1 78.6 17.0 62.1 63.7 67.1 73.5 75.5 78.9 16.8 56.3 58.9 58.7 68.0 68.8 74.1 17.8
Lungd) 12.5 13.6 16.6 20.3 27.5 32.4 19.9 11.6 12.4 15.3 18.0 23.3 27.0 15.4 15.8 17.5 20.2 26.0 37.3 44.3 28.5
Breast 79.2 83.6 88.7 91.2 92.8 93.3 14.1 77.1 84.3 87.5 89.9 90.5 91.9 14.8 79.3 83.6 88.7 91.2 92.8 93.3 14.0
Cervix uteri 78.3 80.3 81.5 80.7 80.3 80.5 2.2 - - - - - - - 78.3 80.3 81.5 80.7 80.3 80.5 2.2
Corpus uteri 82.9 82.0 84.7 86.5 87.8 88.6 5.7 - - - - - - - 82.9 82.0 84.7 86.5 87.8 88.6 5.7
Ovary 60.1 59.4 61.7 61.2 64.7 65.2 5.1 - - - - - - - 60.1 59.4 61.7 61.2 64.7 65.2 5.1
Prostate 59.2 69.3 81.0 92.0 94.2 94.4 35.2 59.2 69.3 81.0 92.0 94.2 94.4 35.2 - - - - - - -
Testis 87.4 90.4 90.7 93.1 94.8 95.1 7.7 87.4 90.4 90.7 93.1 94.8 95.1 7.7 - - - - - - -
Kidney 64.2 67.0 73.7 78.6 82.6 84.1 19.9 63.4 65.3 73.1 78.5 82.2 84.3 20.9 65.8 70.3 74.9 79.0 83.4 83.7 17.9
Bladder 70.7 73.6 76.0 77.2 76.4 76.6 5.9 71.6 75.1 77.8 79.2 78.3 78.6 7.0 67.2 67.2 69.1 69.1 68.2 68.2 1.0
Brain and CNS 40.4 39.9 41.0 42.9 41.6 40.9 0.5 39.1 38.6 40.3 41.3 40.1 39.8 0.7 42.2 41.4 41.8 44.6 43.2 42.2 -
Thyroid 94.5 95.0 98.4 100.0 100.2 100.0 5.5 87.8 89.7 96.0 100.2 100.6 100.4 12.6 95.7 96.0 98.7 99.9 100.1 99.9 4.2
Hodgkin lymphoma 70.1 71.9 76.7 81.1 82.3 84.5 14.4 69.2 69.3 74.7 80.8 81.8 81.8 12.6 71.5 77.3 80.7 81.6 83.2 88.8 17.3
Non-Hodgkin lymphoma 48.3 51.1 56.0 59.4 62.8 64.0 15.7 46.8 49.6 55.0 59.2 62.8 64.8 18.0 50.7 53.3 57.5 59.7 62.8 62.9 12.2
Multiple myeloma 23.5 21.1 29.7 35.0 41.5 46.6 23.1 23.0 19.2 29.9 35.2 41.0 46.9 23.9 24.1 23.3 29.5 34.7 42.0 46.4 22.3
Leukemia 27.5 34.3 42.0 47.7 51.9 53.4 25.9 27.3 33.3 41.8 46.9 52.2 53.4 26.1 27.8 35.5 42.2 48.7 51.6 53.6 25.8
Other and ill-defined 44.5 48.3 57.8 67.6 72.7 74.8 30.3 39.6 44.7 54.0 63.8 69.3 71.7 32.1 50.1 52.6 62.0 71.6 76.1 77.9 27.8

CNS, central nervous system.

a) Absolute percentage change in 5-year relative survival from 1993 to 1995 and 2014 to 2018,

b) Includes the liver and intrahepatic bile duct,

c) Includes the gallbladder and other/unspecified parts of the biliary tract,

d) Includes the lung and bronchus.

Table 7
Crude and age-standardized rates of cancer prevalence by sex on January 1, 2019 in Korea
Site/Type Crude prevalence rates per 100,000a) Age-standardized prevalence rates per 100,000b)
Both sexes Men Women Both sexes Men Women
All sites 3,909.3 3,441.4 4,375.5 2,216.8 2,018.5 2,499.4
Lip, oral cavity, and pharynx 53.7 72.0 35.5 30.9 43.0 20.2
Esophagus 21.9 39.3 4.6 11.0 21.7 2.2
Stomach 593.1 786.2 400.7 304.6 440.6 191.7
Colon and rectum 517.1 616.3 418.4 262.5 347.0 193.7
Liverc) 139.9 210.5 69.5 76.7 122.3 35.3
Gallbladderd) 46.8 48.5 45.2 22.6 26.7 19.4
Pancreas 26.0 27.1 24.9 14.1 15.7 12.8
Larynx 22.3 42.1 2.6 11.1 23.3 1.2
Lunge) 182.5 222.5 142.6 92.8 123.6 68.9
Breast 463.5 3.4 921.8 273.9 1.9 539.4
Cervix uteri 111.3 - 222.2 64.6 - 126.4
Corpus uteri 55.1 - 109.9 32.5 - 64.1
Ovary 44.1 - 88.1 28.4 - 56.4
Prostate 188.8 378.3 - 85.7 200.7 -
Testis 7.3 14.6 - 6.5 12.8 -
Kidney 90.4 122.3 58.6 52.0 73.9 32.2
Bladder 73.5 120.0 27.2 35.2 66.1 11.3
Brain and CNS 24.1 24.7 23.4 19.9 21.1 18.7
Thyroid 843.9 302.5 1,383.3 536.4 196.8 874.0
Hodgkin lymphoma 6.3 7.8 4.8 5.1 6.1 4.0
Non-Hodgkin lymphoma 68.7 78.1 59.3 45.7 54.8 37.2
Multiple myeloma 13.7 14.4 13.0 7.2 8.1 6.3
Leukemia 46.4 51.8 41.0 41.5 46.6 36.4
Other and ill-defined 269.1 259.2 279.0 155.8 165.8 147.6

CNS, central nervous system.

a) Crude prevalence rate: number of prevalent cases divided by the corresponding person-years of observation. Prevalent cases were defined as patients who were diagnosed between January 1, 1999 and December 31, 2018, and who were alive on January 1, 2019. Multiple primary cancer cases were counted multiple times,

b) Age-adjusted using Segi’s world standard population,

c) Includes the liver and intrahepatic bile duct,

d) Includes the gallbladder and other/unspecified parts of the biliary tract,

e) Includes the lung and bronchus.

  • 1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021. Feb. 4[Epub]. https://doi.org/10.3322/caac.21660 Article
  • 2. World Health OrganizationWHO report on cancer: setting priorities, investing wisely and providing care for all. Geneva: World Health Organization; 2020.
  • 3. Shin HR, Won YJ, Jung KW, Kong HJ, Yim SH, Lee JK, et al. Nationwide cancer incidence in Korea, 1999–2001: first result using the national cancer incidence database. Cancer Res Treat. 2005;37:325–31. ArticlePubMedPMC
  • 4. Ajiki W, Tsukuma H, Oshima A. Index for evaluating completeness of registration in population-based cancer registries and estimation of registration rate at the Osaka Cancer Registry between 1966 and 1992 using this index. Nihon Koshu Eisei Zasshi. 1998;45:1011–7. PubMed
  • 5. Statistics Korea [Internet]. Daejeon: Statistics Korea; 2019. [cited 2021 Feb 28]. Available from: http://kosis.kr
  • 6. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, et al. International classification of diseases for oncology. 3rd ed. 1st revGeneva: World Health Organization; 2013.
  • 7. World Health OrganizationInternational statistical classification of diseases and related health problems. 10th rev. Geneva: World Health Organization; 1994.
  • 8. Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, et al. Global cancer observatory: cancer today – data and methods [Internet]. Lyon: International Agency for Research on Cancer; 2020. [cited 2021 Feb 28]. Available from: https://gco.iarc.fr/today/data-sources-methods
  • 9. Cancer incidence in five continents, Vol. XI. Chapter 3. Classification and coding [Internet]. Lyon: International Agency for Research on Cancer; 2020. [cited 2021 Feb 28]. Available from: http://ci5.iarc.fr/CI5-XI/Pages/Chapter3.aspx
  • 10. Young JL Jr, Roffers SD, Ries LA, Fritz AG, Hurlbut AA. SEER summary staging manual 2000: codes and coding instructions. National Cancer Institute, NIH Pub. No. 01-4969Bethesda, MD: National Cancer Institute; 2001.
  • 11. Cancer incidence in five continents, Vol. XI. Chapter 7 Age standardization [Internet]. Lyon: International Agency for Research on Cancer; 2020. [cited 2021 Feb 28]. Available from: http://ci5.iarc.fr/CI5-XI/Pages/Chapter7.aspx
  • 12. Segi M. Cancer mortality for selected sites in 24 countries 1950–1957. Sendai: Tohoku University School of Medicine; 1960.
  • 13. Surveillance Research Program Joinpoint Regression Program, version 4801 [Internet]. Bethesda, MD: Surveillance Research Program, National Cancer Institute; 2020. [cited 2020 Dec 1]. Available from: https://surveillance.cancer.gov/joinpoint/
  • 14. Ederer F, Heise H. Instructions to IBM 650 programmers in processing survival computations. Methodological note, No. 10Bethesda, MD: National Cancer Institute; 1959.
  • 15. Paul Dickman [Internet]. Stockholm: PaulDickman.com; 2016. [cited 2021 Feb 28]. Available from: http://www.pauldickman.com

Figure & Data

REFERENCES

    Citations

    Citations to this article as recorded by  
    • National Expenditures on Anticancer and Immunomodulating Agents During 2013–2022 in Korea
      Jieun Yun, Youngs Chang, Minsol Jo, Yerin Heo, Dong-Sook Kim
      Journal of Korean Medical Science.2025;[Epub]     CrossRef
    • Kindlin-1 promotes gastric cancer cell motility through the Wnt/β-catenin signaling pathway
      Jun-Ho Jang, Jiyoon Jung, Hyeon-Gu Kang, Woong Kim, Won-Jin Kim, Hana Lee, Ju Yeon Cho, Ran Hong, Jeong Won Kim, Joon-Yong Chung, Kyung-Hee Chun, Seok-Jun Kim
      Scientific Reports.2025;[Epub]     CrossRef
    • ACG Clinical Guideline: Diagnosis and Management of Gastric Premalignant Conditions
      Douglas R. Morgan, Juan E. Corral, Dan Li, Elizabeth A. Montgomery, Arnoldo Riquelme, John J. Kim, Bryan Sauer, Shailja C. Shah
      American Journal of Gastroenterology.2025; 120(4): 709.     CrossRef
    • Which factors predict the effectiveness of adjuvant treatment in patients with non-high-risk early-stage cervical cancer? Ancillary analysis of KGOG-1028
      Junhwan Kim, Jieun Jang, Myong Cheol Lim, Moon-Hong Kim, Yun Hwan Kim, Eun Seop Song, Seok Ju Seong, Dong Hoon Suh, Jong-Min Lee, Chulmin Lee, Chel Hun Choi, Sokbom Kang
      Gynecologic Oncology.2025; 196: 10.     CrossRef
    • Prospective Multicenter Observational Study on Postoperative Quality of Life According to Type of Gastrectomy for Gastric Cancer
      Sung Eun Oh, Yun-Suhk Suh, Ji Yeong An, Keun Won Ryu, In Cho, Sung Geun Kim, Ji-Ho Park, Hoon Hur, Hyung-Ho Kim, Sang-Hoon Ahn, Sun-Hwi Hwang, Hong Man Yoon, Ki Bum Park, Hyoung-Il Kim, In Gyu Kwon, Han-Kwang Yang, Byoung-Jo Suh, Sang-Ho Jeong, Tae-Han Ki
      Journal of Gastric Cancer.2025; 25(2): 382.     CrossRef
    • Long-term natural course of patients with lymph node station 6 metastasis after pylorus-preserving gastrectomy
      Sa-Hong Kim, Franco José Signorini, Kyoyoung Park, Chungyoon Kim, Jeesun Kim, Yo-Seok Cho, Seong-Ho Kong, Do-Joong Park, Hyuk-Joon Lee, Han-Kwang Yang
      Gastric Cancer.2025;[Epub]     CrossRef
    • Novel and Effective Blood‐Based miRNA Diagnostic Panel for Gastric Cancer: A Pilot Study in a Japanese Population
      Tatsuro Murano, Ka Yan Chung, Yew Chung Tang, Yuki Kano, Ken Takeuchi, Naoya Sakamoto, Takeshi Kuwata, Yuan Gao, Jit Kong Cheong, He Cheng, Lihan Zhou, Tomonori Yano
      Cancer Medicine.2025;[Epub]     CrossRef
    • Population attributable fractions of modifiable cancer risk factors in Korea: A systematic review
      Mi Ah Han, Seo‐Hee Kim, Eu Chang Hwang, Jae Hung Jung, Sun Mi Park
      Asia-Pacific Journal of Clinical Oncology.2024; 20(2): 299.     CrossRef
    • Timely assessment of 5-year relative survival for patients with thyroid cancer from Taizhou, eastern China: a period analysis
      Jiajia Huang, Jun Cao, Luyao Zhang, Meiyu Fang, Yongran Cheng, Da-Lin Lu, Liangyou Wang, Tianhui Chen
      European Journal of Cancer Prevention.2024; 33(1): 62.     CrossRef
    • Associations Between Fasting Glucose and Cardiovascular Disease Mortality in Cancer Survivors: A Population-based Cohort Study
      Mi-Hyang Jung, Sang-Wook Yi, Sang Joon An, Jee-Jeon Yi, Sang-Hyun Ihm, So-Young Lee, Jong-Chan Youn, Woo-Baek Chung, Hae Ok Jung, Ho-Joong Youn
      CardioMetabolic Syndrome Journal.2024; 4(1): 9.     CrossRef
    • Functional Annotation and Gene Set Analysis of Gastric Cancer Risk Loci in a Korean Population
      Hyojin Pyun, Madhawa Gunathilake, Jeonghee Lee, Il Ju Choi, Young-Il Kim, Joohon Sung, Jeongseon Kim
      Cancer Research and Treatment.2024; 56(1): 191.     CrossRef
    • Incidence and treatment outcomes of ovarian carcinosarcoma from the national cancer registry of Korea
      Hyeong In Ha, Ji Hyun Kim, Jiwon Lim, Yong Jung Song, Young-Joo Won, Myong Cheol Lim
      Journal of Gynecologic Oncology.2024;[Epub]     CrossRef
    • Trends in the incidence and survival outcomes of endometrial cancer in Korea: a nationwide population-based cohort study
      Seung-Hyuk Shim, Jiwon Lim, Ji Hyun Kim, Yeon Jee Lee, Hyeong In Ha, Myong Cheol Lim, Young-Joo Won
      Journal of Gynecologic Oncology.2024;[Epub]     CrossRef
    • Impact of early economic activity loss on all-cause mortality in gastric cancer survivors following curative treatment: a nationwide study in Korea
      Byungyoon Yun, Juyeon Oh, Heejoo Park, Jinsoo Chung, Juho Sim, Jongmin Lee, Yangwook Kim, Jin-Ha Yoon
      Gastric Cancer.2024; 27(6): 1159.     CrossRef
    • Viscum album, as alternative and bridge to palliative chemotherapy in recurrent gallbladder cancer following laparoscopic radical cholecystectomy: a case report
      Joonggyeong Shin, Eunsang Yim, Chang Moo Kang
      Korean Journal of Clinical Oncology.2024; 19(2): 88.     CrossRef
    • Ensemble Deep Learning Model to Predict Lymphovascular Invasion in Gastric Cancer
      Jonghyun Lee, Seunghyun Cha, Jiwon Kim, Jung Joo Kim, Namkug Kim, Seong Gyu Jae Gal, Ju Han Kim, Jeong Hoon Lee, Yoo-Duk Choi, Sae-Ryung Kang, Ga-Young Song, Deok-Hwan Yang, Jae-Hyuk Lee, Kyung-Hwa Lee, Sangjeong Ahn, Kyoung Min Moon, Myung-Giun Noh
      Cancers.2024; 16(2): 430.     CrossRef
    • Clinical and Genetic Characteristics of Early and Advanced Gastric Cancer
      Gi Won Ha, Hong Pil Hwang, Yong Gon Cho, Joonhong Park
      Current Issues in Molecular Biology.2024; 46(2): 1208.     CrossRef
    • Living experiences of older patients with cancer amid the COVID-19 pandemic: A phenomenological study
      Yong Hwan Hyeon, Kyoung Ja Moon
      Journal of Korean Gerontological Nursing.2024; 26(1): 54.     CrossRef
    • Research progress in construction of organic carrier drug delivery platform using tumor microenvironment
      Han Yan, Pengchao Xu, Hailin Cong, Bing Yu, Youqing Shen
      Materials Today Chemistry.2024; 37: 101997.     CrossRef
    • Prediction of Cancer Incidence and Mortality in Korea, 2024
      Kyu-Won Jung, Mee Joo Kang, Eun Hye Park, E Hwa Yun, Hye-Jin Kim, Jeong-Eun Kim, Hyun-Joo Kong, Jeong-Soo Im, Hong Gwan Seo
      Cancer Research and Treatment.2024; 56(2): 372.     CrossRef
    • Cohort Profile: The Korean Radiation Workers Study (KRWS)
      Dalnim Lee, Eun Shil Cha, Soojin Park, Hyoju Sung, Eunbi Noh, Haesu Jeong, Won-Il Jang, Songwon Seo
      International Journal of Epidemiology.2024;[Epub]     CrossRef
    • Obesity and thyroid cancer: unraveling the connection through a systematic review and meta-analysis of cohort studies
      Behnaz Abiri, Amirhossein Ramezani Ahmadi, Ali Valizadeh, Faeze Abbaspour, Majid Valizadeh, Mehdi Hedayati
      Journal of Diabetes & Metabolic Disorders.2024; 23(1): 461.     CrossRef
    • A Comparative Study of Postoperative Complications Associated with Distal Gastrectomy and Pylorus-Preserving Gastrectomy among Gastric Cancer Patients Based on Nationwide Survey Data and Propensity Score Weighting
      Sang-Ho Jeong, Miyeong Park, Kyung Seo, Rock Kim, Jae-Seok Min
      Cancers.2024; 16(12): 2203.     CrossRef
    • Major cardiovascular events in long-term multiple myeloma survivors: a Korean case–control study (the CAREMM-2105 study)
      Jeonghoon Ha, Suein Choi, Seulji Moon, Jinseon Han, Jeongyoon Lee, Ki-Hyun Baek, Seunghoon Han, Sung-Soo Park, Chang-Ki Min
      Clinical and Experimental Medicine.2024;[Epub]     CrossRef
    • Socioeconomic status and cardiovascular mortality in over 170 000 cancer survivors
      Mi-Hyang Jung, Yun-Seok Choi, Sang-Wook Yi, Sang Joon An, Jee-Jeon Yi, Sang-Hyun Ihm, So-Young Lee, Jong-Chan Youn, Woo-Baek Chung, Hae Ok Jung, Ho-Joong Youn
      European Heart Journal - Quality of Care and Clinical Outcomes.2024;[Epub]     CrossRef
    • Changes in Treatment After Gallium-68 Prostate-Specific Membrane Antigen-11 Positron Emission Tomography/Computed Tomography in Patients With Prostate Cancer: A Retrospective Case Series Study
      Si Hyun Kim, Chang Wook Jeong, Minh-Tung Do, Jang Hee Han, Seung-Hwan Jeong, Hyeong Dong Yuk, Ja Hyeon Ku, Hyeon Hoe Kim, Gi Jeong Cheon, Cheol Kwak
      Journal of Urologic Oncology.2024; 22(2): 157.     CrossRef
    • Lived Experiences of Pregnant Women With Cancer in South Korea: A Qualitative Study
      Da Bit Lee, Hae Won Kim, Young Jin Lee, Jieun Kim
      Asian Nursing Research.2024; 18(3): 296.     CrossRef
    • Smoking-attributable Mortality in Korea, 2020: A Meta-analysis of 4 Databases
      Eunsil Cheon, Yeun Soo Yang, Suyoung Jo, Jieun Hwang, Keum Ji Jung, Sunmi Lee, Seong Yong Park, Kyoungin Na, Soyeon Kim, Sun Ha Jee, Sung-il Cho
      Journal of Preventive Medicine and Public Health.2024; 57(4): 327.     CrossRef
    • Risk Factors for 90-Day Readmission Among Patients with Metastatic Spine Tumors in South Korea: A Nationwide Population-Based Study
      Sung Hyun Noh, Hyung Cheol Kim, Sang Hyun Kim, Pyung Goo Cho
      World Neurosurgery.2024; 190: e323.     CrossRef
    • Sargahydroquinoic Acid from Brown Seaweed Induces Apoptosis in High Glucose Treated-Human Colon Cancer HCT116 Cells
      Zhang Jiaqi, Seung-Hui Choi, Daeun Hong, Tai-sun Shin, Jung-Mi Yun
      Journal of the Korean Society of Food Science and Nutrition.2024; 53(7): 708.     CrossRef
    • Height and breast cancer risk in premenopausal Korean women aged under 40 years of age
      Thi Xuan Mai Tran, Yoosoo Chang, Hye Rin Choi, Ria Kwon, Ga-Young Lim, Yoosun Cho, Seungho Ryu, Boyoung Park
      British Journal of Cancer.2024; 131(12): 1913.     CrossRef
    • Risk score model for predicting mortality among patients with lung cancer
      Youn Huh, Hae-Rim Kim, Hwa Jung Kim, Ki Young Son
      Frontiers in Medicine.2024;[Epub]     CrossRef
    • Machine learning-based prediction of pulmonary embolism to reduce unnecessary computed tomography scans in gastrointestinal cancer patients: a retrospective multicenter study
      Joo Seong Kim, Doyun Kwon, Kyungdo Kim, Sang Hyub Lee, Seung-Bo Lee, Kwangsoo Kim, Dongmin Kim, Min Woo Lee, Namyoung Park, Jin Ho Choi, Eun Sun Jang, In Rae Cho, Woo Hyun Paik, Jun Kyu Lee, Ji Kon Ryu, Yong-Tae Kim
      Scientific Reports.2024;[Epub]     CrossRef
    • Anatomical study of perigastric fascial space and guidance for laparoscopic approach
      Guoliang Jin, Shuquan Duan, Ana Guan, Zhepeng Wang, Ranhao Zhang, Wenjuan Qiao, Qiuhong Wang, Liansheng Zheng
      Frontiers in Surgery.2024;[Epub]     CrossRef
    • Machine learning algorithms that predict the risk of prostate cancer based on metabolic syndrome and sociodemographic characteristics: a prospective cohort study
      Tao Thi Tran, Jeonghee Lee, Junetae Kim, Sun-Young Kim, Hyunsoon Cho, Jeongseon Kim
      BMC Public Health.2024;[Epub]     CrossRef
    • Monitoring the Outcomes of Systemic Chemotherapy Including Immune Checkpoint Inhibitor for HER2-Positive Metastatic Gastric Cancer by Liquid Biopsy
      Seung-Hyun Jung, Choong-kun Lee, Woo Sun Kwon, Sujin Yun, Minkyu Jung, Hyo Song Kim, Hyun Cheol Chung, Yeun-Jun Chung, Sun Young Rha
      Yonsei Medical Journal.2023; 64(9): 531.     CrossRef
    • U-shaped association between body mass index and health-related quality of life impairment in Korean cancer survivors: a nationwide representative cross-sectional survey
      Jong Eun Park, Kyoung Eun Yeob, So Young Kim, Chul-Woung Kim, Hye Sook Han, Jong Hyock Park
      Journal of Cancer Survivorship.2023; 17(5): 1522.     CrossRef
    • Imaging for Multiple Myeloma according to the Recent International Myeloma Working Group Guidelines: Analysis of Image Acquisition Techniques and Response Evaluation in Whole-Body MRI according to MY-RADS
      A Yeon Son, Hye Won Chung
      Journal of the Korean Society of Radiology.2023; 84(1): 150.     CrossRef
    • Association between dietary intake of n‐3 polyunsaturated fatty acids and risk of colorectal cancer in the Japanese population: The Japan Collaborative Cohort Study
      Ayako Kato, Chika Okada, Ehab S. Eshak, Hiroyasu Iso, Akiko Tamakoshi
      Cancer Medicine.2023; 12(4): 4690.     CrossRef
    • Incidence and survival rates of primary uterine carcinosarcoma in Korea: a National Cancer Registry study
      Se Ik Kim, Ji Hyun Kim, Cheol Lee, Johyun Ha, Kyu-Won Jung, Myong Cheol Lim
      Journal of Gynecologic Oncology.2023;[Epub]     CrossRef
    • Deep Learning for Estimating Lung Capacity on Chest Radiographs Predicts Survival in Idiopathic Pulmonary Fibrosis
      Hyungjin Kim, Kwang Nam Jin, Seung-Jin Yoo, Chang Hoon Lee, Sang-Min Lee, Hyunsook Hong, Joseph Nathanael Witanto, Soon Ho Yoon
      Radiology.2023;[Epub]     CrossRef
    • Impacts of Subtype on Clinical Feature and Outcome of Male Breast Cancer: Multicenter Study in Korea (KCSG BR16-09)
      Jieun Lee, Keun Seok Lee, Sung Hoon Sim, Heejung Chae, Joohyuk Sohn, Gun Min Kim, Kyung-Hee Lee, Su Hwan Kang, Kyung Hae Jung, Jae-ho Jeong, Jae Ho Byun, Su-Jin Koh, Kyoung Eun Lee, Seungtaek Lim, Hee Jun Kim, Hye Sung Won, Hyung Soon Park, Guk Jin Lee, S
      Cancer Research and Treatment.2023; 55(1): 123.     CrossRef
    • Adherence to Cancer Prevention Guidelines and Cancer Incidence and Mortality: A Population-Based Cohort Study
      Jin-Kyoung Oh, Minji Han, Byungmi Kim, Eun Young Park
      Cancer Research and Treatment.2023; 55(1): 15.     CrossRef
    • Radiologic Review of Small Bowel Malignancies and Their Mimicking Lesions
      Jong Soo Lee, So Hyun Park, Seung Joon Choi
      Journal of the Korean Society of Radiology.2023; 84(1): 110.     CrossRef
    • Association of Dietary Antioxidant Vitamin Intake and Gastric Cancer Risk According to Smoking Status and Histological Subtypes of Gastric Cancer: A Case-Control Study in Korea
      Shin Ah Kim, Jung Hyun Kwak, Chang Soo Eun, Dong Soo Han, Yong Sung Kim, Kyu Sang Song, Bo Youl Choi, Hyun Ja Kim
      Nutrition and Cancer.2023; 75(2): 652.     CrossRef
    • Treatment Patterns, Clinical Outcomes and Health Care Resource Utilisation in Patients with EGFR-mutated Metastatic Non-Small Cell Lung Cancer: A Real-World Study in South Korea
      Cliff Molife, Jae Min Cho, Jennifer Lapthorn, Min Ju Kang, Yulia D’yachkova, Sangmi Kim, Sam Colman, Saerom Kim, Agota Szende, Ji Hyun Park, Hee Kyung Ahn, Min Hee Hong, Kaisa-Leena Taipale, Hye Ryun Kim
      Drugs - Real World Outcomes.2023; 10(1): 131.     CrossRef
    • Lymphocyte activation gene (LAG)-3 is a potential immunotherapeutic target for microsatellite stable, programmed death-ligand 1 (PD-L1)-positive endometrioid endometrial cancer
      Jin Hwa Hong, Hyun Woong Cho, Yung-Taek Ouh, Jae Kwan Lee, Yikyeong Chun
      Journal of Gynecologic Oncology.2023;[Epub]     CrossRef
    • Oncological impact of intraperitoneal chemotherapy after cytoreductive surgery for patients with colorectal peritoneal metastasis: A bi‐institutional retrospective analysis
      Soo Yeun Park, Jun Seok Park, Hye Jin Kim, Jong Gwang Kim, Byung Woog Kang, Jin Ho Baek, Hyeong Rok Kim, Chang Hyun Kim, Young Jin Kim, Gyu‐Seog Choi
      Journal of Surgical Oncology.2023; 127(4): 668.     CrossRef
    • Five-Year Overall Survival and Prognostic Factors in Patients with Lung Cancer: Results from the Korean Association of Lung Cancer Registry (KALC-R) 2015
      Da Som Jeon, Ho Cheol Kim, Se Hee Kim, Tae-Jung Kim, Hong Kwan Kim, Mi Hyung Moon, Kyongmin Sarah Beck, Yang-Gun Suh, Changhoon Song, Jin Seok Ahn, Jeong Eun Lee, Jeong Uk Lim, Jae Hyun Jeon, Kyu-Won Jung, Chi Young Jung, Jeong Su Cho, Yoo-Duk Choi, Seung
      Cancer Research and Treatment.2023; 55(1): 103.     CrossRef
    • Interaction between dietary potassium intake and TNF-α rs1800629 genetic polymorphism in gastric cancer risk: a case–control study conducted in Korea
      Tao Thi Tran, Madhawa Gunathilake, Jeonghee Lee, Il Ju Choi, Young-Il Kim, Jeongseon Kim
      British Journal of Nutrition.2023; 130(5): 887.     CrossRef
    • Effects of Cheonggukjang (Fermented Soybean) on the Development of Colitis-Associated Colorectal Cancer in Mice
      Hyeon-Ji Lim, In-Sun Park, Su-Ji Jeong, Gwang-Su Ha, Hee-Jong Yang, Do-Youn Jeong, Seon-Young Kim, Chan-Hun Jung
      Foods.2023; 12(2): 383.     CrossRef
    • A standardized pathology report for gastric cancer: 2nd edition
      Young Soo Park, Myeong-Cherl Kook, Baek-hui Kim, Hye Seung Lee, Dong-Wook Kang, Mi-Jin Gu, Ok Ran Shin, Younghee Choi, Wonae Lee, Hyunki Kim, In Hye Song, Kyoung-Mee Kim, Hee Sung Kim, Guhyun Kang, Do Youn Park, So-Young Jin, Joon Mee Kim, Yoon Jung Choi,
      Journal of Pathology and Translational Medicine.2023; 57(1): 1.     CrossRef
    • Trends in vitamin D level and risk of vitamin D deficiency after gastrectomy for gastric cancer: A retrospective study of a single high-volume center experience
      Sung Eun Oh, Ho Geun Youn, Seung Jong Oh, Min-Gew Choi, Jun Ho Lee, Tae Sung Sohn, Jae Moon Bae, Ji Yeong An
      Clinical Nutrition ESPEN.2023; 53: 74.     CrossRef
    • A Standardized Pathology Report for Gastric Cancer: 2nd Edition
      Young Soo Park, Myeong-Cherl Kook, Baek-hui Kim, Hye Seung Lee, Dong-Wook Kang, Mi-Jin Gu, Ok Ran Shin, Younghee Choi, Wonae Lee, Hyunki Kim, In Hye Song, Kyoung-Mee Kim, Hee Sung Kim, Guhyun Kang, Do Youn Park, So-Young Jin, Joon Mee Kim, Yoon Jung Choi,
      Journal of Gastric Cancer.2023; 23(1): 107.     CrossRef
    • Changing trends in the incidence and spectrum of cancers between 1990 and 2021 among HIV-infected patients in Busan, Korea
      Soon Ok Lee, Jeong Eun Lee, Yong Ki Sim, Shinwon Lee, Woo Seog Ko, Jinmi Kim, Jin Suk Kang, Hyunjin Son, Sun Hee Lee
      Journal of Infection and Chemotherapy.2023; 29(6): 571.     CrossRef
    • Korean Practice Guidelines for Gastric Cancer 2022: An Evidence-based, Multidisciplinary Approach
      Tae-Han Kim, In-Ho Kim, Seung Joo Kang, Miyoung Choi, Baek-Hui Kim, Bang Wool Eom, Bum Jun Kim, Byung-Hoon Min, Chang In Choi, Cheol Min Shin, Chung Hyun Tae, Chung sik Gong, Dong Jin Kim, Arthur Eung-Hyuck Cho, Eun Jeong Gong, Geum Jong Song, Hyeon-Su Im
      Journal of Gastric Cancer.2023; 23(1): 3.     CrossRef
    • Standard follow-up after curative surgery for advanced gastric cancer: secondary analysis of a multicentre randomized clinical trial (KLASS-02)
      Sin Hye Park, Woo Jin Hyung, Han-Kwang Yang, Young-Kyu Park, Hyuk-Joon Lee, Ji Yeong An, Wook Kim, Hyoung-Il Kim, Hyung-Ho Kim, Seung Wan Ryu, Hoon Hur, Min-Chan Kim, Seong-Ho Kong, Gyu Seok Cho, Jin-Jo Kim, Do Joong Park, Young-Woo Kim, Jong Won Kim, Joo
      British Journal of Surgery.2023; 110(4): 449.     CrossRef
    • 3,3′-Diindolylmethane Augments 5-Fluorouracil-InducedGrowth Suppression in Gastric Cancer Cells through Suppression of the Akt/GSK-3β and WNT/Beta-Catenin
      Cong Shan Li, Thi Van Nguyen, Ok Hee Chai, Byung Hyun Park, Ju-Seog Lee, Soo Mi Kim, Xueliang Wu
      Journal of Oncology.2023; 2023: 1.     CrossRef
    • Epidemiology and comorbidities in idiopathic pulmonary fibrosis: a nationwide cohort study
      Jang Ho Lee, Hyung Jun Park, Seonok Kim, Ye-Jee Kim, Ho Cheol Kim
      BMC Pulmonary Medicine.2023;[Epub]     CrossRef
    • Role of breast cancer screening in the overdiagnosis of thyroid cancer: results from a cross-sectional nationwide survey
      Eunhye Lee, Sung Hoon Jeong, Chung Mo Nam, Jae Kwan Jun, Eun-Cheol Park
      BMC Women's Health.2023;[Epub]     CrossRef
    • Pancreatoduodenectomy following neoadjuvant chemotherapy in duodenal adenocarcinoma
      Dongjin Seo, Bo Gyeom Park, Dawn Jung, Ho Kyoung Hwang, Sung Hyun Kim, Seung Soo Hong, Chang Moo Kang
      Annals of Hepato-Biliary-Pancreatic Surgery.2023; 27(1): 114.     CrossRef
    • A comparison of machine learning models and Cox proportional hazards models regarding their ability to predict the risk of gastrointestinal cancer based on metabolic syndrome and its components
      Tao Thi Tran, Jeonghee Lee, Madhawa Gunathilake, Junetae Kim, Sun-Young Kim, Hyunsoon Cho, Jeongseon Kim
      Frontiers in Oncology.2023;[Epub]     CrossRef
    • Trajectory of physical activity frequency and cancer risk: Findings from a population-based cohort study
      Thi Phuong Thao Tran, Ngoc Minh Luu, Thi Tra Bui, Minji Han, Min Kyung Lim, Jin-Kyoung Oh
      European Review of Aging and Physical Activity.2023;[Epub]     CrossRef
    • Association of Breast Cancer Family History With Breast Density Over Time in Korean Women
      Thi Xuan Mai Tran, Yoosoo Chang, Soyeoun Kim, Huiyeon Song, Seungho Ryu, Boyoung Park
      JAMA Network Open.2023; 6(3): e232420.     CrossRef
    • Interactive effect of the empirical lifestyle index for insulin resistance with the common genetic susceptibility locus rs2423279 for colorectal cancer
      Jimi Kim, Jeonghee Lee, Jae Hwan Oh, Hee Jin Chang, Dae Kyung Sohn, Aesun Shin, Jeongseon Kim
      British Journal of Nutrition.2023; 129(9): 1563.     CrossRef
    • Role of neoadjuvant treatment in resectable pancreatic cancer according to vessel invasion and increase of CA19‐9 levels
      Hyeong Seok Kim, Mirang Lee, Youngmin Han, Jae Seung Kang, Yoon Hyung Kang, Hee Ju Sohn, Wooil Kwon, Dong Ho Lee, Jin‐Young Jang
      Journal of Hepato-Biliary-Pancreatic Sciences.2023; 30(7): 924.     CrossRef
    • Clinical Outcomes of Resectional Roux-en-Y Gastric Bypass, Compared to Sleeve Gastrectomy for Severe Obesity
      Yo-Seok Cho, Ji-Hyeon Park, JeeSun Kim, Sa-Hong Kim, Min Kyu Kang, Yeon-Ju Huh, Yun-Suhk Suh, Seong-Ho Kong, Do-Joong Park, Han-Kwang Yang, Minseon Park, Young Min Cho, Hyuk-Joon Lee
      Obesity Surgery.2023; 33(5): 1338.     CrossRef
    • Effect of Sevoflurane on the Proliferation of A549 Lung Cancer Cells
      Sangwon Yun, Kyongsik Kim, Keuna Shin, Hanmi Park, Sunyeul Lee, Yongsup Shin, Aung Soe Paing, Songyi Choi, Chaeseong Lim
      Medicina.2023; 59(3): 613.     CrossRef
    • Clinical features and Surgical Outcome of Clear Cell Papillary Renal Cell Tumor: result from a prospective cohort
      Si Hyun Kim, Jang Hee Han, Seung-hwan Jeong, Hyeong Dong Yuk, Ja Hyeon Ku, Cheol Kwak, Hyeon Hoe Kim, Kyung Chul Moon, Chang Wook Jeong
      BMC Urology.2023;[Epub]     CrossRef
    • Association between Posttreatment Serum Platelet-to-Lymphocyte Ratio and Distant Metastases in Patients with Hepatocellular Carcinoma Receiving Curative Radiation Therapy
      Dong Soo Lee, Chang Wook Kim, Hee Yeon Kim, Young-Mi Ku, Yoo Dong Won, Su-Lim Lee, Der Sheng Sun
      Cancers.2023; 15(7): 1978.     CrossRef
    • Development and external validation of nomograms for predicting individual survival in patients with ovarian clear cell carcinoma
      Xiaoshi Liu, Huaiwu Lu, Ying Zhou, Xiaoran Long, Qing Li, Guanglei Zhuang, Xia Yin, Wen Di
      Cancer Medicine.2023; 12(10): 11385.     CrossRef
    • Real-World Study Evaluating Safety and Effectiveness of Axitinib in Korean Patients with Renal Cell Carcinoma after Failure of One Prior Systemic Therapy
      Sang Joon Shin, Jae Lyun Lee, Tae Gyun Kwon, Byoung Young Shim, Ho Seok Chung, Sang-Hee Kim, Se Hoon Park
      Cancer Research and Treatment.2023; 55(2): 643.     CrossRef
    • Risk of upper gastrointestinal cancer and death in persons with negative screening results: results from the National Cancer Screening Program in South Korea
      Xuan Quy Luu, Kyeongmin Lee, Jae Kwan Jun, Mina Suh, Kyu-Won Jung, Il Ju Choi, Kui Son Choi
      Gastric Cancer.2023; 26(4): 580.     CrossRef
    • Prediction of Cancer Incidence and Mortality in Korea, 2023
      Kyu-Won Jung, Mee Joo Kang, Eun Hye Park, E Hwa Yun, Hye-Jin Kim, Hyun-Joo Kong, Jeong-Soo Im, Hong Gwan Seo
      Cancer Research and Treatment.2023; 55(2): 400.     CrossRef
    • Trends and Patterns of Cancer Burdens by Region and Income Level in Korea: A National Representative Big Data Analysis
      Yoon-Sun Jung, Seok-Jun Yoon
      Cancer Research and Treatment.2023; 55(2): 408.     CrossRef
    • Descriptive Analysis of Gastric Cancer Mortality in Korea, 2000-2020
      Tung Hoang, Hyeongtaek Woo, Sooyoung Cho, Jeeyoo Lee, Sayada Zartasha Kazmi, Aesun Shin
      Cancer Research and Treatment.2023; 55(2): 603.     CrossRef
    • The lived experience of colorectal cancer patients with a temporary ileostomy and the patient’s perception of the ostomy nurses’ educational interventions
      Hye Ri Choi, Hyun Suk Park, YongEun Hong, Young Ae Kim
      Supportive Care in Cancer.2023;[Epub]     CrossRef
    • Prognostic significances of PD-L1- and CTLA-4-positive T cells and positive correlations of immunosuppressive marker expression between cancer tissue and peripheral blood in patients with gastric cancer
      Kun Hee Lee, So Jung Kim, Jin Seok Woo, Seung Yoon Lee, Jooyeon Jhun, Jeonghyeon Moon, Yoon Ju Jung, Mi-La Cho, Kyo Young Song
      Frontiers in Immunology.2023;[Epub]     CrossRef
    • Incidence of dysphagia requiring medical attention in various types of cancers: A nationwide population-based cohort study
      SuYeon Kwon, Gowun Kim, Seungwoo Cha, Kyungdo Han, Nam-Jong Paik, Won-Seok Kim
      Supportive Care in Cancer.2023;[Epub]     CrossRef
    • Association of polypharmacy with all‐cause mortality and adverse events among elderly colorectal cancer survivors
      Dong‐Woo Choi, Hyejung Kang, Hyun‐Soo Zhang, Hoyol Jhang, Wonjeong Jeong, Sohee Park
      Cancer.2023; 129(17): 2705.     CrossRef
    • Meso-jejunal lymph node dissection has a survival benefit in patients with remnant gastric cancer
      Sung Eun Oh, Min-Gew Choi, Jun Ho Lee, Tae Sung Sohn, Jae Moon Bae, Ji Yeong An, Paolo Aurello
      PLOS ONE.2023; 18(5): e0285554.     CrossRef
    • Prediction of ECOG Performance Status of Lung Cancer Patients Using LIME-Based Machine Learning
      Hung Viet Nguyen, Haewon Byeon
      Mathematics.2023; 11(10): 2354.     CrossRef
    • Changes in cervical dysplasia, carcinoma in situ, and cervical cancer after expanding the National Cancer Screening Program to younger women in Korea
      Woorim Kim, Sungyoun Chun, Sang Ah Lee
      International Journal for Quality in Health Care.2023;[Epub]     CrossRef
    • Mortality risk according to smoking trajectories after cancer diagnosis among Korean male cancer survivors: A population-based cohort study
      Thi Tra Bui, Minji Han, Ngoc Minh Luu, Thi Phuong Thao Tran, Sun Young Kim, Young Ae Kim, Min Kyung Lim, Jin-Kyoung Oh
      Tobacco Induced Diseases.2023; 21(May): 1.     CrossRef
    • Recent Trends of Medical Expenses Associated with Radiation Therapy in Korea Based on HIRA Big Data
      Jeong Eun Lee, Kyungmi Yang, Yong Chan Ahn, Won Park, Seung Jae Huh
      Cancer Research and Treatment.2023; 55(3): 758.     CrossRef
    • Asia‐Pacific Leukemia Consortium: An innovative and collaborative initiative to improve care of leukemia and related diseases in the Asia‐Pacific region
      Zhentang Lao, Eric Wai Choi Tse, Suporn Chuncharunee, Yok Lam Kwong, Andrew Wei, Bor Sheng Ko, Jin Seok Kim, Soo Chin Ng, Jianxiang Wang, Yeow Tee Goh
      Asia-Pacific Journal of Clinical Oncology.2023; 19(6): 655.     CrossRef
    • Survival rate of thyroid cancer in the Asian countries: a systematic review and meta-analysis study
      Soheil Hassanipour, Reza Zare, Alireza Shahedi, Hamed Delam
      Endocrine.2023; 82(2): 237.     CrossRef
    • Effects of prior endoscopic resection on recurrence in patients with T1 colorectal cancer who underwent radical surgery
      Hyun Jin Joo, Jee Ung Seok, Byung Chang Kim, Dong-eun Lee, Bun Kim, Kyung Su Han, Chang Won Hong, Dae Kyung Sohn, Dong Woon Lee, Sung Chan Park, Hee Jin Chang, Jae Hwan Oh
      International Journal of Colorectal Disease.2023;[Epub]     CrossRef
    • Etiology of Isolated Third, Fourth, and Sixth Cranial Nerve Palsies with a Cancer History
      Dongyoung Lee, Kyung-Ah Park
      Journal of the Korean Ophthalmological Society.2023; 64(6): 532.     CrossRef
    • Testicular Cancer Incidence among Obstructive Sleep Apnea (OSA) Patients: South Korean National Health Insurance Data
      Marn Joon Park, Kyung-Do Han, Jae Hoon Cho, Ji Ho Choi
      Cancers.2023; 15(13): 3273.     CrossRef
    • Differential Prognostic Value of Vascular Invasion in Resected Lung Adenocarcinomas According to Epidermal Growth Factor Receptor Mutational Status
      Kyung Hee Lee, Jin-Haeng Chung, Sukki Cho, Jong-Seok Lee, Hyungjin Kim
      Clinical Lung Cancer.2023; 24(7): e291.     CrossRef
    • Interaction between retinol intake and ISX rs5755368 polymorphism in colorectal cancer risk: a case–control study in a Korean population
      Anh Quynh Bui, Madhawa Gunathilake, Jeonghee Lee, Jae Hwan Oh, Hee Jin Chang, Dae Kyung Sohn, Aesun Shin, Jeongseon Kim
      Scientific Reports.2023;[Epub]     CrossRef
    • Sex‐specific differences in colorectal cancer: A multicenter retrospective cohort study
      Hyun Jin Joo, Hyun Seok Lee, Byung Ik Jang, Dae Bum Kim, Jae Hyun Kim, Jae Jun Park, Hyun Gun Kim, Il Hyun Baek, Jun Lee, Bun Kim
      Cancer Reports.2023;[Epub]     CrossRef
    • Computed Tomography–based Prognostication in Lung Adenocarcinomas through Histopathological Feature Learning: A Retrospective Multicenter Study
      Kyung Hee Lee, Jong Hyuk Lee, Samina Park, Yoon Kyung Jeon, Doo Hyun Chung, Young Tae Kim, Jin Mo Goo, Hyungjin Kim
      Annals of the American Thoracic Society.2023; 20(7): 1020.     CrossRef
    • Associations between Physical Activity and Incidence of Cancer among Overweight Adults in Korea: Results from the Health Examinees-G Study
      Jaesung Choi, JooYong Park, Ji-Eun Kim, Miyoung Lee, Daehee Kang, Aesun Shin, Ji-Yeob Choi
      Cancer Prevention Research.2023; 16(7): 405.     CrossRef
    • Preferred versus Actual Place of Care and Factors Associated with Home Discharge among Korean Patients with Advanced Cancer: A Retrospective Cohort Study
      In Young Hwang, Yohan Han, Min Sun Kim, Kyae Hyung Kim, Belong Cho, Wonho Choi, Yejin Kim, Shin Hye Yoo, Sun Young Lee
      Healthcare.2023; 11(13): 1939.     CrossRef
    • Systematic Review of Lung Cancer Screening: Advancements and Strategies for Implementation
      Daniela Amicizia, Maria Francesca Piazza, Francesca Marchini, Matteo Astengo, Federico Grammatico, Alberto Battaglini, Irene Schenone, Camilla Sticchi, Rosa Lavieri, Bruno Di Silverio, Giovanni Battista Andreoli, Filippo Ansaldi
      Healthcare.2023; 11(14): 2085.     CrossRef
    • Trends in incidence and overdiagnosis of thyroid cancer in China, Japan, and South Korea
      Yongtian Lin, Yu Wu
      Cancer Science.2023; 114(10): 4052.     CrossRef
    • Complication After Gastrectomy for Gastric Cancer According to Hospital Volume: Based on Korean Gastric Cancer Association-Led Nationwide Survey Data
      Sang-Ho Jeong, Moon-Won Yoo, Miyeong Park, Kyung Won Seo, Jae-Seok Min
      Journal of Gastric Cancer.2023; 23(3): 462.     CrossRef
    • Renal function change after radical cystectomy for urothelial carcinoma patients with a solitary kidney may be independent of urinary diversion type
      Gyeong Hun Kim, Hyeong Dong Yuk, Chang Wook Jeong, Cheol Kwak, Ja Hyeon Ku
      Investigative and Clinical Urology.2023; 64(5): 457.     CrossRef
    • Serum 25-Hydroxyvitamin D Levels and Risk of Colorectal Cancer: An Age-Stratified Analysis
      Yejin Kim, Yoosoo Chang, Yoosun Cho, Jiwon Chang, Kyungeun Kim, Dong-Il Park, Soo-Kyung Park, Hee-Kyung Joh, Mi Kyung Kim, Chanmin Kim, Sarah H. Wild, Christopher D. Byrne, Seungho Ryu
      Gastroenterology.2023; 165(4): 920.     CrossRef
    • Comparison of the Effects of DOTA and NOTA Chelators on 64Cu-Cudotadipep and 64Cu-Cunotadipep for Prostate Cancer
      Inki Lee, Min Hwan Kim, Kyongkyu Lee, Keumrok Oh, Hyunwoo Lim, Jae Hun Ahn, Yong Jin Lee, Gi Jeong Cheon, Dae Yoon Chi, Sang Moo Lim
      Diagnostics.2023; 13(16): 2649.     CrossRef
    • Combinations of lifestyle behaviors and cancer risk among Korean adults
      Ngoc Minh Luu, Thi Tra Bui, Thi Phuong Thao Tran, Thi Huyen Trang Nguyen, Jin-Kyoung Oh
      Scientific Reports.2023;[Epub]     CrossRef
    • Prognostic value of CT-defined ground-glass opacity in early-stage lung adenocarcinomas: a single-center study and meta-analysis
      Jong Hyuk Lee, Yunhee Choi, Hyunsook Hong, Young Tae Kim, Jin Mo Goo, Hyungjin Kim
      European Radiology.2023; 34(3): 1905.     CrossRef
    • Prognostic Value of Hematological Markers in Head and Neck Cancer Patients With a History of Hematological Malignancy
      Jooin Bang, Oh-Hyeong Lee, Geun-Jeon Kim, Sang-Yeon Kim, Dong-Il Sun
      Korean Journal of Otorhinolaryngology-Head and Neck Surgery.2023; 66(10): 678.     CrossRef
    • Serum KL-6 levels predict the occurrence and severity of treatment-related interstitial lung disease in lung cancer
      Hwa Kyung Park, Chang-Seok Yoon, Young-Ok Na, Jae-Kyeong Lee, Hyung-Joo Oh, Ha-Young Park, Bo-Gun Kho, Tae-Ok Kim, Hong-Joon Shin, Yong-Soo Kwon, In-Jae Oh, Yu-Il Kim, Sung-Chul Lim, Young-Chul Kim, Cheol-Kyu Park
      Scientific Reports.2023;[Epub]     CrossRef
    • Sublobar Resection versus Stereotactic Body Radiation Therapy for Clinical Stage I Non–Small Cell Lung Cancer: A Study Using Data from the Korean Nationwide Lung Cancer Registry
      Jeonghee Yun, Jong Ho Cho, Tae Hee Hong, Kyungmi Yang, Yong Chan Ahn, Hong Kwan Kim
      Cancer Research and Treatment.2023; 55(4): 1171.     CrossRef
    • Gastroesophageal reflux disease and risk of cancer: Findings from the Korean National Health Screening Cohort
      Chi Lan Tran, Minji Han, Byungmi Kim, Eun Young Park, Young Il Kim, Jin‐Kyoung Oh
      Cancer Medicine.2023; 12(18): 19163.     CrossRef
    • Short-term efficacy of additional laparoscopic-assisted radical gastrectomy after non-curative endoscopic submucosal dissection for early gastric cancer
      Zhi-Hao Hu, Jing-Tao Wang, Rui-Xin Li, Guo-Jun Wang, Bu-Lang Gao
      Langenbeck's Archives of Surgery.2023;[Epub]     CrossRef
    • A Phase 3 Randomized Clinical Trial to Compare Efficacy and Safety between Combination Therapy and Monotherapy in Elderly Patients with Advanced Gastric Cancer (KCSG ST13-10)
      Keun-Wook Lee, Dae Young Zang, Min-Hee Ryu, Hye Sook Han, Ki Hyang Kim, Mi-Jung Kim, Sung Ae Koh, Sung Sook Lee, Dong-Hoe Koo, Yoon Ho Ko, Byeong Seok Sohn, Jin Won Kim, Jin Hyun Park, Byung-Ho Nam, In Sil Choi
      Cancer Research and Treatment.2023; 55(4): 1250.     CrossRef
    • Preoperative Haematologic Markers for the Differentiation of Endometrial Cancer from Benign Endometrial Lesions in Postmenopausal Patients with Endometrial Masses
      Yong Jung Song, Hwi Gon Kim, Hyung Joon Yoon, Kyung Un Choi, Dong Soo Suh, Ki Hyung Kim
      Cancer Management and Research.2023; Volume 15: 1111.     CrossRef
    • Enhanced Risk Stratification in Early-Stage Endometrial Cancer: Integrating POLE through Droplet Digital PCR and L1CAM
      Seungyeon Joe, Miseon Lee, Jun Kang, Joori Kim, Sook-Hee Hong, Sung Jong Lee, Keun Ho Lee, Ahwon Lee
      Cancers.2023; 15(19): 4899.     CrossRef
    • Diagnostic performance and prognostic value of CT-defined visceral pleural invasion in early-stage lung adenocarcinomas
      Woo Hyeon Lim, Kyung Hee Lee, Jong Hyuk Lee, Hyungin Park, Ju Gang Nam, Eui Jin Hwang, Jin-Haeng Chung, Jin Mo Goo, Samina Park, Young Tae Kim, Hyungjin Kim
      European Radiology.2023; 34(3): 1934.     CrossRef
    • Prognostication of lung adenocarcinomas using CT-based deep learning of morphological and histopathological features: a retrospective dual-institutional study
      Taehee Lee, Kyung Hee Lee, Jong Hyuk Lee, Samina Park, Young Tae Kim, Jin Mo Goo, Hyungjin Kim
      European Radiology.2023; 34(5): 3431.     CrossRef
    • Gastric Cancer Incidence and Mortality After Endoscopic Resection of Gastric Adenoma: A Nationwide Cohort Study
      Jae Myung Park, Songhee Cho, Ga-Yeong Shin, Jayoun Lee, Minjee Kim, Hyeon Woo Yim
      American Journal of Gastroenterology.2023; 118(12): 2166.     CrossRef
    • Comparison of complications between laparoscopic and open gastrectomies for early gastric cancer by a nationwide propensity score-matched cohort study
      Jeong Ho Song, Jae-Seok Min
      Scientific Reports.2023;[Epub]     CrossRef
    • Comparative Risk of Type 2 Diabetes after Gastrectomy and Endoscopic Resection for Gastric Cancer: A Nationwide Cohort Study
      Yeongkeun Kwon, Jin-Won Kwon, Jiyun Kim, Dohyang Kim, Jinseub Hwang, Jane Ha, Shin-Hoo Park, Sungsoo Park
      Journal of the American College of Surgeons.2023; 237(6): 902.     CrossRef
    • Mammographic Breast Density and Risk of Ovarian Cancer in Korean Women
      Thi Xuan Mai Tran, Soyeoun Kim, Boyoung Park
      Cancer Epidemiology, Biomarkers & Prevention.2023; 32(12): 1690.     CrossRef
    • Deep learning-based prognostication in idiopathic pulmonary fibrosis using chest radiographs
      Taehee Lee, Su Yeon Ahn, Jihang Kim, Jong Sun Park, Byoung Soo Kwon, Sun Mi Choi, Jin Mo Goo, Chang Min Park, Ju Gang Nam
      European Radiology.2023; 34(7): 4206.     CrossRef
    • How should the healthcare system support cancer survivors? Survivors’ and health professionals’ expectations and perception on comprehensive cancer survivorship care in Korea: a qualitative study
      Su Jung Lee, Dal-Lae Jin, Young Ae Kim, Hyun-Ju Seo, Seok-Jun Yoon
      BMC Cancer.2023;[Epub]     CrossRef
    • Parental intention to vaccinate daughters with the human papillomavirus vaccine in Korea: a nationwide cross-sectional survey
      Yejin Ha, Kyeongmin Lee, Bomi Park, Mina Suh, Jae Kwan Jun, Kui Son Choi
      Epidemiology and Health.2023; 45: e2023076.     CrossRef
    • Socioeconomic inequality in organized and opportunistic screening for colorectal cancer: results from the Korean National Cancer Screening Survey, 2009-2021
      Xuan Quy Luu, Kyeongmin Lee, Jae Kwan Jun, Mina Suh, Kui Son Choi
      Epidemiology and Health.2023; 45: e2023086.     CrossRef
    • Riboflavin intake, MTRR genetic polymorphism (rs1532268) and gastric cancer risk in a Korean population: a case–control study
      Y-Thanh Lu, Madhawa Gunathilake, Jeonghee Lee, Il Ju Choi, Young-Il Kim, Jeongseon Kim
      British Journal of Nutrition.2022; 127(7): 1026.     CrossRef
    • Cause-specific mortality rate of ovarian cancer in the presence of competing risks of death: a nationwide population-based cohort study
      Seung-Hyuk Shim, Myong Cheol Lim, Dahhay Lee, Young-Joo Won, Hyeong In Ha, Ha Kyun Chang, Hyunsoon Cho
      Journal of Gynecologic Oncology.2022;[Epub]     CrossRef
    • Association between metabolic syndrome and its components and incident colorectal cancer in a prospective cohort study
      Tao Thi Tran, Madhawa Gunathilake, Jeonghee Lee, Jeongseon Kim
      Cancer.2022; 128(6): 1230.     CrossRef
    • Prognostic impact of neutrophilia and lymphopenia on survival in anal cancer treated with definitive concurrent chemoradiotherapy: a retrospective multicenter study
      Eunji Kim, Tae Hyung Kim, Wonguen Jung, Kyubo Kim, Ah Ram Chang, Hae Jin Park, Hyeon Kang Koh, Semie Hong, Kyung Hwan Kim, Jee Suk Chang, Woong Sub Koom, Won Il Jang, Mi-Sook Kim
      International Journal of Clinical Oncology.2022; 27(3): 553.     CrossRef
    • Body Mass Index and Thyroid Cancer Risk: A Pooled Analysis of Half a Million Men and Women in the Asia Cohort Consortium
      Aesun Shin, Sooyoung Cho, Doeun Jang, Sarah Krull Abe, Eiko Saito, Md Shafiur Rahman, Md Rashedul Islam, Norie Sawada, Xiao-Ou Shu, Woon-Puay Koh, Atsuko Sadakane, Ichiro Tsuji, Yumi Sugawara, Hidemi Ito, Chisato Nagata, Sue K. Park, Jian-Min Yuan, Jeongs
      Thyroid.2022; 32(3): 306.     CrossRef
    • Cervical conization before primary radical hysterectomy has a protective effect on disease recurrence in early cervical cancer: A two-center matched cohort study according to surgical approach
      Se Ik Kim, Bo Ram Choi, Hee Seung Kim, Hyun Hoon Chung, Jae-Weon Kim, Noh Hyun Park, Yong-Sang Song, Chel Hun Choi, Maria Lee
      Gynecologic Oncology.2022; 164(3): 535.     CrossRef
    • Influence of Fasting Glucose Level on Gastric Cancer Incidence in a Prospective Cohort Study
      Tao Thi Tran, Jeonghee Lee, Madhawa Gunathilake, Hyunsoon Cho, Jeongseon Kim
      Cancer Epidemiology, Biomarkers & Prevention.2022; 31(1): 254.     CrossRef
    • Spade-Shaped Anastomosis after Laparoscopic Proximal Gastrectomy Using Double Suture Anchoring between the Posterior Wall of the Esophagus and the Anterior Wall of the Stomach (SPADE Operation): A Case Series
      Sin Hye Park, Harbi Khalayleh, Sung Gon Kim, Sang Soo Eom, Fahed Merei, Junsun Ryu, Young-Woo Kim
      Cancers.2022; 14(2): 379.     CrossRef
    • The association of dietary fibre intake and the IL13 rs20541 polymorphism with the risk of gastric cancer: a case-control study in Korea
      Tao Thi Tran, Madhawa Gunathilake, Jeonghee Lee, Il Ju Choi, Young-Il Kim, Jeongseon Kim
      European Journal of Clinical Nutrition.2022; 76(7): 1031.     CrossRef
    • Population attributable fractions of modifiable cancer risk factors in Korea: a systematic review protocol
      Mi Ah Han, Eu Chang Hwang, Jae Hung Jung, Seo-Hee Kim, Sun Mi Park
      BMJ Open.2022; 12(1): e055758.     CrossRef
    • The incidence and clinical features of familial pancreatic cancer in Korea
      Minseob Kim, Hongbeom Kim, Youngmin Han, Heeju Sohn, Mirang Lee, Yoon Hyung Kang, Hyeong Seok Kim, Wooil Kwon, Jin‐Young Jang
      Journal of Hepato-Biliary-Pancreatic Sciences.2022; 29(6): 659.     CrossRef
    • Neoadjuvant chemotherapy with gemcitabine and cisplatin followed by selective bladder preservation chemoradiotherapy in muscle-invasive urothelial carcinoma of bladder
      Hyun Hwan Sung, Hana Kim, Ryul Kim, Chan Kyo Kim, Ghee Young Kwon, Won Park, Wan Song, Byong Chang Jeong, Se Hoon Park
      Investigative and Clinical Urology.2022; 63(2): 168.     CrossRef
    • Effect of colorectal cancer screening on long‐term survival of colorectal cancer patients: Results of the Korea National Cancer Screening Program
      Xuan Quy Luu, Kyeongmin Lee, Jae Kwan Jun, Mina Suh, Kyu‐Won Jung, Kui Son Choi
      International Journal of Cancer.2022; 150(12): 1958.     CrossRef
    • Conditional relative survival of patients with endometrial cancer: a Korean National Cancer Registry study
      Dong Wook Shin, Kyu-Won Jung, Johyun Ha, Jaeman Bae
      Journal of Gynecologic Oncology.2022;[Epub]     CrossRef
    • Trends in cervical cancer screening rates among Korean women: results of the Korean National Cancer Screening Survey, 2005–2020
      Hye Young Shin, Yun Yeong Lee, Soo Yeon Song, Bomi Park, Mina Suh, Kui Son Choi, Jae Kwan Jun
      Journal of Gynecologic Oncology.2022;[Epub]     CrossRef
    • The interaction between glycemic index, glycemic load, and the genetic variant ADIPOQ T45G (rs2241766) in the risk of colorectal cancer: a case–control study in a Korean population
      Y-Thanh Lu, Madhawa Gunathilake, Jeonghee Lee, Jae Hwan Oh, Hee Jin Chang, Dae Kyung Sohn, Aesun Shin, Jeongseon Kim
      European Journal of Nutrition.2022; 61(5): 2601.     CrossRef
    • Coffee consumption and its interaction with the genetic variant AhR rs2066853 in colorectal cancer risk: a case–control study in Korea
      Y-Thanh Lu, Madhawa Gunathilake, Jeonghee Lee, Youngyo Kim, Jae Hwan Oh, Hee Jin Chang, Dae Kyung Sohn, Aesun Shin, Jeongseon Kim
      Carcinogenesis.2022; 43(3): 203.     CrossRef
    • Trends in Incidence and Survival of Patients With Thymic Epithelial Tumor in a High-Incidence Asian Country: Analysis of the Korean Central Cancer Registry 1999 to 2017
      Dong Wook Shin, Jong Ho Cho, Johyun Ha, Kyu-Won Jung
      Journal of Thoracic Oncology.2022; 17(6): 827.     CrossRef
    • No Prognostic Impact of Staging Brain MRI in Patients with Stage IA Non–Small Cell Lung Cancer
      Ju G. Nam, Hyunsook Hong, Seung Hong Choi, Chang Min Park, Jin Mo Goo, Young Tae Kim, Hyungjin Kim
      Radiology.2022; 303(3): 632.     CrossRef
    • Notification of Terminal Status and Advance Care Planning in Patients with Cancer
      Si Won Lee
      The Korean Journal of Hospice and Palliative Care.2022; 25(1): 42.     CrossRef
    • Cyclin D1 Serves as a Poor Prognostic Biomarker in Stage I Gastric Cancer
      Se-Il Go, Gyung Hyuck Ko, Won Sup Lee, Jeong-Hee Lee, Sang-Ho Jeong, Young-Joon Lee, Soon Chan Hong, Woo Song Ha
      Current Issues in Molecular Biology.2022; 44(3): 1395.     CrossRef
    • Assessment of textbook outcome after lobectomy for early‐stage non‐small cell lung cancer in a Korean institution: A retrospective study
      Woo Sik Yu, Jaeyong Shin, Jung A Son, Joonho Jung, Seokjin Haam
      Thoracic Cancer.2022; 13(8): 1211.     CrossRef
    • Comparison of the Clinical Outcomes of Reconstruction Methods After Distal Gastrectomy: A Systematic Review and Meta-Analysis Based on Randomized Controlled Trials
      Jae-Seok Min, Rock Bum Kim, Kyung Won Seo, Sang-Ho Jeong
      Journal of Gastric Cancer.2022; 22(2): 83.     CrossRef
    • PIVKA-II as a surrogate marker for prognosis in patients with localized hepatocellular carcinoma receiving stereotactic body radiotherapy
      Ick Joon Cho, Jae-Uk Jeong, Taek-Keun Nam, Young-Eun Joo, Sung-Bum Cho, Yong-Hyub Kim, Ju-Young Song, Mee Sun Yoon, Sung-Ja Ahn, Woong-Ki Chung
      Radiation Oncology Journal.2022; 40(1): 20.     CrossRef
    • Chronic pancreatitis and cancer risk in a matched cohort study using national claims data in South Korea
      Minji Han, Thi Phuong Thao Tran, Jin-Kyoung Oh
      Scientific Reports.2022;[Epub]     CrossRef
    • Trends in the Incidence and Survival Rates of Primary Ovarian Clear Cell Carcinoma Compared to Ovarian Serous Carcinoma in Korea
      Se Ik Kim, Hyeong In Ha, Kyung Jin Eoh, Jiwon Lim, Young-Joo Won, Myong Cheol Lim
      Frontiers in Oncology.2022;[Epub]     CrossRef
    • Simultaneous Integrated Boost Volumetric Modulated Arc Therapy for Rectal Cancer: Long-Term Results after Protocol-Based Treatment
      Dong Soo Lee, Seong-Taek Oh, Chang-Hyeok Ahn, Jaeim Lee, Kil-Yong Lee, Hiun Suk Chae, Sung Soo Kim, Sang Woo Kim, Kyung Jin Seo, Alessandro Granito
      Journal of Oncology.2022; 2022: 1.     CrossRef
    • Predictors of Recurrence in Patients with Papillary Thyroid Carcinoma: Does Male Sex Matter?
      Hyeji Kim, Hyungju Kwon, Byung-In Moon
      Cancers.2022; 14(8): 1896.     CrossRef
    • Prediction of Cancer Incidence and Mortality in Korea, 2022
      Kyu-Won Jung, Young-Joo Won, Mee Joo Kang, Hyun-Joo Kong, Jeong-Soo Im, Hong Gwan Seo
      Cancer Research and Treatment.2022; 54(2): 345.     CrossRef
    • Reevaluation of the expanded indications in undifferentiated early gastric cancer for endoscopic submucosal dissection
      Jiyoung Yoon, Seung-Yeon Yoo, Young Soo Park, Kee Don Choi, Beom Su Kim, Moon-Won Yoo, In Seob Lee, Jeong Hwan Yook, Ga Hee Kim, Hee Kyong Na, Ji Yong Ahn, Jeong Hoon Lee, Kee Wook Jung, Do Hoon Kim, Ho June Song, Gin Hyug Lee, Hwoon-Yong Jung
      World Journal of Gastroenterology.2022; 28(15): 1548.     CrossRef
    • Exploring socio-demographic, physical, psychological, and quality of life-related factors related with fear of cancer recurrence in stomach cancer survivors: a cross-sectional study
      Jinyoung Shin, Dong Wook Shin, Jungkwon Lee, JiHye Hwang, Ji Eun Lee, BeLong Cho, Yun–Mi Song
      BMC Cancer.2022;[Epub]     CrossRef
    • Single-Center Real-World Experience of Multiple Myeloma in the 21st Century
      Hyungwoo Cho, Shin Kim, Kyoungmin Lee, Eun Hee Kang, Jung Sun Park, Cheolwon Suh
      The Korean Journal of Medicine.2022; 97(2): 125.     CrossRef
    • Nanocarrier-based co-delivery approaches of chemotherapeutics with natural P-glycoprotein inhibitors in the improvement of multidrug resistance cancer therapy
      Shadab Md, Nabil A. Alhakamy, Priyanka Sharma, Mohammad Shahnawaze Ansari, Bapi Gorain
      Journal of Drug Targeting.2022; 30(8): 801.     CrossRef
    • Association of institutional transition of cancer care with mortality in elderly patients with lung cancer: a retrospective cohort study using national claim data
      Kyu-Tae Han, Jongwha Chang, Dong-Woo Choi, Seungju Kim, Dong Jun Kim, Yoon-Jung Chang, Sun Jung Kim
      BMC Cancer.2022;[Epub]     CrossRef
    • Staging and response assessment of lymphoma: a brief review of the Lugano classification and the role of FDG-PET/CT
      Kwai Han Yoo
      Blood Research.2022; 57(S1): S75.     CrossRef
    • Association between Low-Dose Computed Tomography Results and 1-Year Smoking Cessation in a Residential Smoking Cessation Program
      Da-Som Shin, Hye-Mi Noh, Hong Ji Song, Kyung Hee Park, Young-Gyun Seo, Yu-Jin Paek
      International Journal of Environmental Research and Public Health.2022; 19(9): 5510.     CrossRef
    • Distress, Family Resilience, and Quality of Life among Family Caregivers of Cancer Patients Undergoing Chemotherapy: The Moderating Role of Family Resilience
      Son-Hee Ahn, Soo Hyun Kim
      Korean Journal of Adult Nursing.2022; 34(2): 225.     CrossRef
    • Association between HER2 heterogeneity and clinical outcomes of HER2-positive gastric cancer patients treated with trastuzumab
      Kyunghye Bang, Jaekyung Cheon, Young Soo Park, Hyung-Don Kim, Min-Hee Ryu, Yangsoon Park, Meesun Moon, Hyungeun Lee, Yoon-Koo Kang
      Gastric Cancer.2022; 25(4): 794.     CrossRef
    • Effect of gastric cancer screening on long-term survival of gastric cancer patients: results of Korean national cancer screening program
      Xuan Quy Luu, Kyeongmin Lee, Jae Kwan Jun, Mina Suh, Kyu-Won Jung, Kui Son Choi
      Journal of Gastroenterology.2022; 57(7): 464.     CrossRef
    • The Associations of Dietary Intake of High Sodium and Low Zinc with Gastric Cancer Mortality: A Prospective Cohort Study in Korea
      Jung Hyun Kwak, Chan Hyuk Park, Chang Soo Eun, Dong Soo Han, Yong Sung Kim, Kyu Sang Song, Bo Youl Choi, Hyun Ja Kim
      Nutrition and Cancer.2022; 74(10): 3501.     CrossRef
    • Development of Korean CARcinogen EXposure: Assessment of the Exposure Intensity of Carcinogens by Industry
      Dong-Hee Koh, Ju-Hyun Park, Sang-Gil Lee, Hwan-Cheol Kim, Hyejung Jung, Inah Kim, Sangjun Choi, Donguk Park
      Safety and Health at Work.2022; 13(3): 308.     CrossRef
    • Natural Language Processing for Information Extraction of Gastric Diseases and Its Application in Large-Scale Clinical Research
      Gyuseon Song, Su Jin Chung, Ji Yeon Seo, Sun Young Yang, Eun Hyo Jin, Goh Eun Chung, Sung Ryul Shim, Soonok Sa, Moongi Simon Hong, Kang Hyun Kim, Eunchan Jang, Chae Won Lee, Jung Ho Bae, Hyun Wook Han
      Journal of Clinical Medicine.2022; 11(11): 2967.     CrossRef
    • Current status of the gastric cancer screening program in Korea
      Young-Il Kim, Il Ju Choi
      Journal of the Korean Medical Association.2022; 65(5): 250.     CrossRef
    • Association between Dietary Fiber Intake and Colorectal Adenoma
      Hyojin Kim, Jiyoung Youn, Sun Young Yang, Ji Hyun Song, Young Sun Kim, Jung Eun Lee
      Nutrition and Cancer.2022; 74(10): 3446.     CrossRef
    • Deep Learning Prediction of Survival in Patients with Chronic Obstructive Pulmonary Disease Using Chest Radiographs
      Ju Gang Nam, Hye-Rin Kang, Sang Min Lee, Hyungjin Kim, Chanyoung Rhee, Jin Mo Goo, Yeon-Mok Oh, Chang-Hoon Lee, Chang Min Park
      Radiology.2022; 305(1): 199.     CrossRef
    • Clinical Implication of Preoperative Renal Function on Oncological Outcomes in Patients with Upper Tract Urothelial Carcinoma after Radical Nephroureterectomy
      Tae Heon Kim, Hyun Hwan Sung, Jong Jin Oh, Seok Ho Kang, Ho Kyung Seo, Bumsik Hong, Ja Hyeon Ku, Byong Chang Jeong
      Biomedicines.2022; 10(6): 1340.     CrossRef
    • Recent Improvements in the Treatment of High-Risk Thyroid Cancer
      Eun Kyung Lee
      Korean Society for Head and Neck Oncology.2022; 38(1): 1.     CrossRef
    • Association between Masticatory Difficulty and Handgrip Strength in Korean Adult Cancer Survivors
      Geon Jung, Ga Eun Nam, Youn Huh, Yusun Her, Eun Sik Lee, Jeemin Choo, Jinkyung Chang, Yang-Hyun Kim, Kyung-Hwan Cho
      Korean Journal of Family Practice.2022; 12(3): 179.     CrossRef
    • Retreatment with progestin for recurrence after complete response with fertility-sparing treatment in patients with endometrial cancer
      A Jin Lee, Seung-Hyuk Shim, Nae Ry Kim, Eun Jung Yang, Kyeong A So, Sun Joo Lee, Ji Young Lee, Tae Jin Kim, Soon-Beom Kang
      International Journal of Gynecological Cancer.2022; 32(8): 1001.     CrossRef
    • Association between Micronutrient Intake and Breast Cancer Risk According to Body Mass Index in South Korean Adult Women: A Cohort Study
      Huiyeon Song, Ansun Jeong, Thi Xuan Mai Tran, Jiseon Lee, Mikyung Kim, Boyoung Park
      Nutrients.2022; 14(13): 2644.     CrossRef
    • Health Care Utilization and Anti-Cancer Drug Expenditure for Six Solid Cancers in Korea From 2007 to 2019
      Juhee Park, Kyeongjun Moon, Dong-Sook Kim
      Frontiers in Oncology.2022;[Epub]     CrossRef
    • Clinical implications of neoadjuvant chemotherapy in advanced endometrial cancer: a multi-center retrospective cohort study
      Hyunji Lim, Seung Hyun Bang, Yeorae Kim, Sang Hyun Cho, Wonkyo Shin, Se Ik Kim, Tae Hun Kim, Dong Hoon Suh, Myong Cheol Lim, Jae-Weon Kim
      BMC Cancer.2022;[Epub]     CrossRef
    • Association between dietary intake networks identified through a Gaussian graphical model and the risk of cancer: a prospective cohort study
      Madhawa Gunathilake, Tung Hoang, Jeonghee Lee, Jeongseon Kim
      European Journal of Nutrition.2022; 61(8): 3943.     CrossRef
    • Cancer Incidence and Mortality in Asian Countries: A Trend Analysis
      Junjie Huang, Chun Ho Ngai, Yunyang Deng, Man Sing Tin, Veeleah Lok, Lin Zhang, Jinqiu Yuan, Wanghong Xu, Zhi-Jie Zheng, Martin C. S. Wong
      Cancer Control.2022;[Epub]     CrossRef
    • Effect of miR-196a2 rs11614913 Polymorphism on Cancer Susceptibility: Evidence From an Updated Meta-Analysis
      Md. Abdul Aziz, Tahmina Akter, Mohammad Safiqul Islam
      Technology in Cancer Research & Treatment.2022;[Epub]     CrossRef
    • High Expression of PRNP Predicts Poor Prognosis in Korean Patients with Gastric Cancer
      Minseok Choi, SeongRyeol Moon, Hyo Jin Eom, Seung Mook Lim, Yon Hui Kim, Seungyoon Nam
      Cancers.2022; 14(13): 3173.     CrossRef
    • Trend Analysis and Prediction of Hepatobiliary Pancreatic Cancer Incidence and Mortality in Korea
      Hyeong Min Park, Young-Joo Won, Mee Joo Kang, Sang-Jae Park, Sun-Whe Kim, Kyu-Won Jung, Sung-Sik Han
      Journal of Korean Medical Science.2022;[Epub]     CrossRef
    • Effect of National Oral Health Screening Program on the Risk of Head and Neck Cancer: A Korean National Population-Based
      Chan Woo Wee, Hyo-Jung Lee, Jae-Ryun Lee, Hyejin Lee, Min-Jeong Kwoen, Woo-Jin Jeong, Keun-Yong Eom
      Cancer Research and Treatment.2022; 54(3): 709.     CrossRef
    • Predictive Value of Interstitial Lung Abnormalities for Postoperative Pulmonary Complications in Elderly Patients with Early-stage Lung Cancer
      Won Gi Jeong, Yun-Hyeon Kim, Jong Eun Lee, In-Jae Oh, Sang Yun Song, Kum Ju Chae, Hye Mi Park
      Cancer Research and Treatment.2022; 54(3): 744.     CrossRef
    • Pre-treatment Nutritional Risk Assessment by NRS-2002 Predicts Prognosis in Patients With Advanced Biliary Tract Cancer: A Single Center Retrospective Study
      Se Eung Oh, Juong Soon Park, Hei-Cheul Jeung
      Clinical Nutrition Research.2022; 11(3): 183.     CrossRef
    • The necessity of continuing cervical cancer screening of elderly Korean women aged 65 years or older
      Sumin Cho, Seon‐Mi Lee, Sanghoon Lee, Hyun‐Woong Cho, Kyung‐Jin Min, Jin‐Hwa Hong, Jae‐Yun Song, Jae‐Kwan Lee, Nak‐Woo Lee
      Diagnostic Cytopathology.2022; 50(10): 482.     CrossRef
    • Current Evidence for a Paradigm Shift in Gastric Cancer Prevention From Endoscopic Screening toHelicobacter pyloriEradication in Korea
      Young-Il Kim, Il Ju Choi
      Journal of Gastric Cancer.2022; 22(3): 169.     CrossRef
    • Epidemiology of Gastric Cancer in Korea: Trends in Incidence and Survival Based on Korea Central Cancer Registry Data (1999–2019)
      Sin Hye Park, Mee Joo Kang, E Hwa Yun, Kyu-Won Jung
      Journal of Gastric Cancer.2022; 22(3): 160.     CrossRef
    • Association Between Statins and the Risk of Kidney Cancer Incidence and Mortality Using the Korean National Health Insurance Claims Database
      Dong-Sook Kim, Hyun Jung Kim, Hyeong Sik Ahn
      Cancer Control.2022;[Epub]     CrossRef
    • Recent trends in opioid prescriptions in Korea from 2002 to 2015 based on the Korean NHIS-NSC cohort
      Joungyoun Kim, Sang-Jun Shin, Jihyun Yoon, Hyeong-Seop Kim, Jae-woo Lee, Ye-seul Kim, Yonghwan Kim, Hyo-Sun You, Hee-Taik Kang
      Epidemiology and Health.2022; 44: e2022029.     CrossRef
    • Family history of breast cancer, mammographic breast density and breast cancer risk: Findings from a cohort study of Korean women
      Thi Xuan Mai Tran, Soyeoun Kim, Huiyeon Song, Boyoung Park
      The Breast.2022; 65: 180.     CrossRef
    • Healthcare vulnerability disparities in pancreatic cancer treatment and mortality using the Korean National Sample Cohort: a retrospective cohort study
      Sung Hoon Jeong, Hyeon Ji Lee, Choa Yun, Il Yun, Yun Hwa Jung, Soo Young Kim, Hee Seung Lee, Sung-In Jang
      BMC Cancer.2022;[Epub]     CrossRef
    • Chrysin-Induced G Protein-Coupled Estrogen Receptor Activation Suppresses Pancreatic Cancer
      Hyun Kyung Lim, Hee Jung Kwon, Ga Seul Lee, Jeong Hee Moon, Joohee Jung
      International Journal of Molecular Sciences.2022; 23(17): 9673.     CrossRef
    • Number of Tumor Foci as a Risk Factor for Recurrence in Papillary Thyroid Carcinoma: Does It Improve Predictability?
      Hyungju Kwon, Woosung Lim, Byung-In Moon
      Cancers.2022; 14(17): 4141.     CrossRef
    • Difference in medical service use among Korean gastric cancer survivors according to regional healthcare vulnerabilities: a cohort study
      Sung Hoon Jeong, Jae Hong Joo, Minah Park, Choa Yun, Soo Hyun Kang, Eun-Cheol Park, Yoon Dae Han, Sung-In Jang
      Supportive Care in Cancer.2022; 30(11): 9233.     CrossRef
    • Epidemiologic outlook of therapy‐related myeloid neoplasms and selection of high‐risk patients: A Korean nationwide study
      Hyerim Ha, Hyo Jeong Kim, Ju Hyun Park, Aesun Shin, Kyu Na Lee, Kyungdo Han, Na Rae Lee, Junshik Hong
      Cancer.2022; 128(21): 3888.     CrossRef
    • Machine learning-based prediction model for late recurrence after surgery in patients with renal cell carcinoma
      Hyung Min Kim, Seok-Soo Byun, Jung Kwon Kim, Chang Wook Jeong, Cheol Kwak, Eu Chang Hwang, Seok Ho Kang, Jinsoo Chung, Yong-June Kim, Yun-Sok Ha, Sung-Hoo Hong
      BMC Medical Informatics and Decision Making.2022;[Epub]     CrossRef
    • Multi-center study of residual gastric volume and bowel preparation after the usage of 1L and 2L polyethylene glycol in Korea
      Yong Eun Park, Su Jin Jeong, Jin Lee, Jongha Park, Seung Jung Yu, Sam Ryong Jee, Tae Oh Kim
      Medicine.2022; 101(38): e30795.     CrossRef
    • Metabolic parameters on baseline 18F-FDG PET/CT are potential predictive biomarkers for immunotherapy in patients with head and neck squamous cell carcinoma
      Hye Ryeong Kwon, Junhun Cho, Sehhoon Park, Se-Hoon Lee, Myung-Ju Ahn, Joon Young Choi, Kyung-Han Lee, Hyun Ae Jung, Seung Hwan Moon
      Frontiers in Medicine.2022;[Epub]     CrossRef
    • Relationship between Incidental Abnormalities on Screening Thoracic Computed Tomography and Mortality: A Long-Term Follow-Up Analysis
      Jong Eun Lee, Won Gi Jeong, Hyo-Jae Lee, Yun-Hyeon Kim, Kum Ju Chae, Yeon Joo Jeong
      Korean Journal of Radiology.2022; 23(10): 998.     CrossRef
    • Novel management of expected post-radiotherapy complications in hepatocellular carcinoma patients: a case report
      Sung Hoon Chang, Tae Suk Kim, Yong Hwan Jeon, Nuri Hyun Jung, Dae Hee Choi
      Journal of Liver Cancer.2022; 22(2): 183.     CrossRef
    • Improvement of Gastroscopy Classification Performance Through Image Augmentation Using a Gradient-Weighted Class Activation Map
      Hyun-Sik Ham, Han-Sung Lee, Jung-Woo Chae, Hyun Chin Cho, Hyun-Chong Cho
      IEEE Access.2022; 10: 99361.     CrossRef
    • The association between prostatitis and risk of prostate cancer: a National Health Insurance Database study
      Gyoohwan Jung, Jung Kwon Kim, Hasung Kim, Jungkuk Lee, Sung Kyu Hong
      World Journal of Urology.2022; 40(11): 2781.     CrossRef
    • INTRADURAL DISC HERNIATION MIMICKING A SPINAL TUMOR, CASE PRESENTATION AND REVIEW OF THE LITERATURE
      Ersin Hacıyakupoğlu, Burak Kınalı, Evren Yüvrük, Milos Arsenovic, Sebahattin Hacıyakupoğlu
      Journal of Turkish Spinal Surgery.2022; 33(4): 157.     CrossRef
    • Clinical Application of Circulating Tumor DNA Analysis
      Dongju Won, Jinho Heo, Hongkyung Kim, Saeam Shin, Seung-Tae Lee
      Laboratory Medicine Online.2022; 12(4): 235.     CrossRef
    • Global trend of colorectal cancer, prevention, and control in China: challenges and strategies
      HaiNing CHEN, ZiQiang WANG, YongYang YU, Meng QIU, Lie YANG, WenJian MENG, Cun WANG, Yuan LI, Li LI, Heng XU, CanHua HUANG, ZongGuang ZHOU
      SCIENTIA SINICA Vitae.2022;[Epub]     CrossRef
    • Recent Changes in the Incidence of Thyroid Cancer in Korea between 2005 and 2018: Analysis of Korean National Data
      Yun Mi Choi, Jiwoo Lee, Mi Kyung Kwak, Min Ji Jeon, Tae Yong Kim, Eun-Gyoung Hong, Won Bae Kim, Won Gu Kim
      Endocrinology and Metabolism.2022; 37(5): 791.     CrossRef
    • Relationship Between Physical Activity Levels and Thyroid Cancer Risk: A Prospective Cohort Study in Korea
      Anh Quynh Bui, Madhawa Gunathilake, Jeonghee Lee, Eun Kyung Lee, Jeongseon Kim
      Thyroid.2022; 32(11): 1402.     CrossRef
    • Global, Regional, and National Burdens with Temporal Trends of Early-, Intermediate-, and Later-Onset Gastric Cancer from 1990 to 2019 and Predictions up to 2035
      Fei-Long Ning, Nan-Nan Zhang, Zhe-Ming Zhao, Wan-Ying Du, Yong-Ji Zeng, Masanobu Abe, Jun-Peng Pei, Chun-Dong Zhang
      Cancers.2022; 14(21): 5417.     CrossRef
    • Menstrual and Reproductive Factors for Gastric Cancer in Postmenopausal Women: The 2007–2020 Korea National Health and Nutrition Examination Survey
      Heekyoung Song, Jung Yoon Park, Ju Myung Song, Youngjae Yoon, Yong-Wook Kim
      International Journal of Environmental Research and Public Health.2022; 19(21): 14468.     CrossRef
    • Trends of Colorectal Cancer Screening Rates in Korea: Korean National Cancer Screening Survey 2005–2020
      Bomi Park, Yun Yeong Lee, Soo Yeon Song, Hye Young Shin, Mina Suh, Kui Son Choi, Jae Kwan Jun
      Gut and Liver.2022; 16(6): 930.     CrossRef
    • Association of Late Marriage and Low Childbirth with Cervical Cancer Screening among Korean Women: Results from a Nationwide Survey
      Hye Young Shin, Bomi Park, Mina Suh, Kui Son Choi, Jae Kwan Jun
      Cancers.2022; 14(2): 327.     CrossRef
    • Interobserver Variability Prediction of Primary Gross Tumor in a Patient with Non-Small Cell Lung Cancer
      Wonjoong Cheon, Seonghoon Jeong, Jong Hwi Jeong, Young Kyung Lim, Dongho Shin, Se Byeong Lee, Doo Yeul Lee, Sung Uk Lee, Yang Gun Suh, Sung Ho Moon, Tae Hyun Kim, Haksoo Kim
      Cancers.2022; 14(23): 5893.     CrossRef
    • Recent Progress in Immunotherapy for Metastatic Colorectal Cancer
      Seong Jung Kim, Jun Lee
      Journal of Digestive Cancer Research.2022; 10(2): 65.     CrossRef
    • Hematopoietic Effects of Angelica gigas Nakai Extract on Cyclophosphamide-Induced Myelosuppression
      Mincheol Kang, Seojin Park, Yuseong Chung, Je-Oh Lim, Jae Seon Kang, Jun Hong Park
      Plants.2022; 11(24): 3476.     CrossRef
    • Improving quality control in the routine practice for histopathological interpretation of gastrointestinal endoscopic biopsies using artificial intelligence
      Young Sin Ko, Yoo Mi Choi, Mujin Kim, Youngjin Park, Murtaza Ashraf, Willmer Rafell Quiñones Robles, Min-Ju Kim, Jiwook Jang, Seokju Yun, Yuri Hwang, Hani Jang, Mun Yong Yi, Anwar P.P. Abdul Majeed
      PLOS ONE.2022; 17(12): e0278542.     CrossRef
    • Synergistic Effect of HAD-B1 and Afatinib Against Gefitinib Resistance of Non-Small Cell Lung Cancer
      Si Yeon Song, Ji Hye Park, So-Jung Park, In-Cheol Kang, Hwa-Seung Yoo
      Integrative Cancer Therapies.2022;[Epub]     CrossRef
    • Clinical utilization of radiation therapy in Korea between 2017 and 2019
      Eunji Kim, Won Il Jang, Kwangmo Yang, Mi-Sook Kim, Hyung Jun Yoo, Eun Kyung Paik, Heejin Kim, Jaesun Yoon
      Radiation Oncology Journal.2022; 40(4): 251.     CrossRef
    • Comparison of optimal bowel cleansing effects of 1L polyethylene glycol with ascorbic acid versus sodium picosulfate with magnesium citrate: A randomized controlled study
      Jun Lee, Seong-Jung Kim, Sang-Wook Kim, Hyo-Yeop Song, Geom Seog Seo, Dong-Hyun Kim, Dae-Seong Myung, Hyun-Soo Kim, Young-Eun Joo, So Yeong Kim, Miquel Vall-llosera Camps
      PLOS ONE.2022; 17(12): e0279631.     CrossRef
    • Metformin and Cervical Cancer Risk in Patients with Newly Diagnosed Type 2 Diabetes: A Population-Based Study in Korea
      Hyun Min Kim, Min Jin Kang, Sun Ok Song
      Endocrinology and Metabolism.2022; 37(6): 929.     CrossRef
    • Analysis of HR-HPV Prevalence among Unvaccinated Busan Women
      Dong Hyeok Kim, Kyung Eun Lee
      Biomedical Science Letters.2022; 28(4): 229.     CrossRef
    • Effect of mammography screening on the long-term survival of breast cancer patients: results from the National Cancer Screening Program in Korea
      Xuan Quy Luu, Kyeongmin Lee, Jae Kwan Jun, Mina Suh, Kyu-Won Jung, Kui Son Choi
      Epidemiology and Health.2022; 44: e2022094.     CrossRef
    • Epidemiologic Outlook of Therapy-Related Myeloid Neoplasms and Selection of High-Risk Patients: Korean Nationwide Study
      Hyerim Ha, Hyo Jeong Kim, Ju Hyun Park, Aesun Shin, Kyu Na Lee, Kyungdo Han, Na Rae Lee, Junshik Hong
      SSRN Electronic Journal .2022;[Epub]     CrossRef
    • Trends in breast cancer screening rates among Korean women: results from the Korean National Cancer Screening Survey, 2005-2020
      Soo Yeon Song, Yun Yeong Lee, Hye Young Shin, Bomi Park, Mina Suh, Kui Son Choi, Jae Kwan Jun
      Epidemiology and Health.2022; 44: e2022111.     CrossRef
    • Human papillomavirus vaccine uptake in South Korea
      Jin Young Choi, Miseon Kim, Byung-Su Kwon, Su Jin Jeong, Dong Hoon Suh, Kidong Kim, Yong Beom Kim, Jae Hong No
      Clinical and Experimental Obstetrics & Gynecology.2022;[Epub]     CrossRef
    • Post-Diagnostic Statin Use Reduces Mortality in South Korean Patients with Dyslipidemia and Gastrointestinal Cancer
      Kyu-Tae Han, Seungju Kim
      Journal of Clinical Medicine.2021; 10(11): 2361.     CrossRef
    • Diagnostic workup and indications for antireflux surgery
      Hyoung-Il Kim
      Foregut Surgery.2021; 1(2): 13.     CrossRef
    • Quercetin Induces Anticancer Activity by Upregulating Pro-NAG-1/GDF15 in Differentiated Thyroid Cancer Cells
      Yukyung Hong, Jaehak Lee, Hyunjin Moon, Chang H. Ryu, Jungirl Seok, Yuh-Seog Jung, Junsun Ryu, Seung J. Baek
      Cancers.2021; 13(12): 3022.     CrossRef
    • Practical issues and research trends of oncofertility in gynecologic cancer
      Jeong-Yeol Park
      Korean Journal of Women Health Nursing.2021; 27(2): 64.     CrossRef
    • Clinicopathologic and Prognostic Association of GRP94 Expression in Colorectal Cancer with Synchronous and Metachronous Metastases
      Sumi Yun, Sukmook Lee, Ho-Young Lee, Hyeon Jeong Oh, Yoonjin Kwak, Hye Seung Lee
      International Journal of Molecular Sciences.2021; 22(13): 7042.     CrossRef
    • Association between bacteria other than Helicobacter pylori and the risk of gastric cancer
      Madhawa Gunathilake, Jeonghee Lee, Il Ju Choi, Young‐Il Kim, Jeongseon Kim
      Helicobacter.2021;[Epub]     CrossRef
    • The Associations of Dietary Iron Intake and the Transferrin Receptor (TFRC) rs9846149 Polymorphism with the Risk of Gastric Cancer: A Case–Control Study Conducted in Korea
      Tao Thi Tran, Madhawa Gunathilake, Jeonghee Lee, Il Ju Choi, Young-Il Kim, Jeongseon Kim
      Nutrients.2021; 13(8): 2600.     CrossRef
    • Disparities in Cancer-Related Avoidable Mortality by the Level of Area Deprivation in South Korea
      Woorim Kim, Seongkyeong Jang, Gangeun Lee, Yoon Jung Chang
      International Journal of Environmental Research and Public Health.2021; 18(15): 7856.     CrossRef
    • Cancer Patients’ Willingness to Take COVID-19 Vaccination: A Nationwide Multicenter Survey in Korea
      June Young Chun, Se Ik Kim, Eun Young Park, Sang-Yoon Park, Su-Jin Koh, Yongjun Cha, Heon Jong Yoo, Jae Young Joung, Hong Man Yoon, Bang Wool Eom, Chul Min Park, Ji-Youn Han, Miso Kim, Dae-Won Lee, Jae-Weon Kim, Bhumsuk Keam, Maria Lee, Tae Min Kim, Young
      Cancers.2021; 13(15): 3883.     CrossRef
    • Effect of the Interaction between Dietary Patterns and the Gastric Microbiome on the Risk of Gastric Cancer
      Madhawa Gunathilake, Jeonghee Lee, Il Ju Choi, Young-Il Kim, Jeongseon Kim
      Nutrients.2021; 13(8): 2692.     CrossRef
    • Prognostic Value of the Anatomic Region of Metastatic Lymph Nodes in the Current TNM Staging of Gastric Cancer
      Oh Jeong, Mi Ran Jung, Ji Hoon Kang
      Journal of Gastric Cancer.2021; 21(3): 236.     CrossRef
    • Investigation of Information Acquisition Channel for Prostate Cancer High-Risk Group
      Yun-Sok Ha, Kwang Taek Kim, Wook Nam, Hongzoo Park, Sangjun Yoo, Chan Ho Lee, Ho Seok Chung, Woo Suk Choi, Jiyoun Kim, Jaeeun Shin, Jeong Hyun Kim, Cheol Kwak
      The Korean Journal of Urological Oncology.2021; 19(3): 174.     CrossRef
    • An update on immunotherapy with PD-1 and PD-L1 blockade
      Sung Ae Koh
      Yeungnam University Journal of Medicine.2021; 38(4): 308.     CrossRef
    • Impact of Computed Tomography-Based, Artificial Intelligence-Driven Volumetric Sarcopenia on Survival Outcomes in Early Cervical Cancer
      Qingling Han, Se Ik Kim, Soon Ho Yoon, Taek Min Kim, Hyun-Cheol Kang, Hak Jae Kim, Jeong Yeon Cho, Jae-Weon Kim
      Frontiers in Oncology.2021;[Epub]     CrossRef
    • Salvage radiation therapy for postoperative locoregionally recurrent non-small cell lung cancer: a single-center experience
      Yoon Young Jo, Su Ssan Kim, Si Yeol Song, Eun Kyung Choi
      Radiation Oncology Journal.2021; 39(3): 210.     CrossRef
    • Korean Gastric Cancer Association-Led Nationwide Survey on Surgically Treated Gastric Cancers in 2019

      Journal of Gastric Cancer.2021; 21(3): 221.     CrossRef
    • MNNG-Regulated Differentially Expressed Genes that Contribute to Cancer Development in Stomach Cells
      Tae-Jin Kim, Myeong-Kwan Kim, Dongju Jung
      Korean Journal of Clinical Laboratory Science.2021; 53(4): 353.     CrossRef
    • Twenty-year incidence trend of hematologic malignancies in the Republic of Korea: 1999-2018
      Won-Ju Park, Joo-heon Park, Seunghyeon Cho, Myung Geun Shin
      BLOOD RESEARCH.2021; 56(4): 301.     CrossRef
    • Vitexin Inhibits Gastric Cancer Growth and Metastasis through HMGB1-mediated Inactivation of the PI3K/AKT/mTOR/HIF-1α Signaling Pathway
      Peng Zhou, Zi-Han Zheng, Tao Wan, Jie Wu, Chuan-Wen Liao, Xue-Jun Sun
      Journal of Gastric Cancer.2021; 21(4): 439.     CrossRef
    • Lymph Node Ratio as a Good Prognostic Factor for Patients with Pathologic N3a Breast Cancer with 10 or More Metastatic Axillary Lymph Nodes
      Seo Won Jung, Soo Young Lim, Yong Min Na, Young Jae Ryu, Jin Seong Cho, Jung Han Yoon, Min Ho Park
      Journal of Breast Disease.2021; 9(2): 56.     CrossRef
    • Analysis of Clinicopathological Features and Risk Factors for Severe Complications after Gastrectomy for Gastric Cancer in Elderly Patients
      Feng Zhao, In Cho
      Soonchunhyang Medical Science.2021; 27(2): 75.     CrossRef
    • Disparities in the Diagnosis, Treatment, and Survival Rate of Cervical Cancer among Women with and without Disabilities
      Jin Young Choi, Kyoung Eun Yeob, Seung Hwa Hong, So Young Kim, Eun-Hwan Jeong, Dong Wook Shin, Jong Heon Park, Gil-won Kang, Hak Soon Kim, Jong Hyock Park, Ichiro Kawachi
      Cancer Control.2021;[Epub]     CrossRef

    • PubReader PubReader
    • ePub LinkePub Link
    • Cite
      CITE
      export Copy Download
      Close
      Download Citation
      Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.
      Format:
      • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
      • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
      Include:
      • Citation for the content below
      Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2018
      Cancer Res Treat. 2021;53(2):301-315.   Published online March 17, 2021
      DOI: https://doi.org/10.4143/crt.2021.291
      Close
    • XML DownloadXML Download
    • 0
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2018
    Image Image Image Image Image Image Image
    Fig. 1 The five common sites of cancer incidence by age group and sex in Korea, 2018. (A) Men. (B) Women. Numbers in the graph are age-specific incidence rates per 100,000. CNS, central nervous system.
    Fig. 2 Age-specific incidence rates of common cancers for 2018 in Korea. (A) Men. (B) Women.
    Fig. 3 Annual age-standardized cancer incidence and mortality rates by sex for all sites from 1983 to 2018 in Korea. Age standardization was based on Segi’s world standard population.
    Fig. 4 Trends in age-standardized incidences of selected cancers by sex from 1999 to 2018 in Korea. (A) Men. (B) Women. Age standardization was based on Segi’s world standard population.
    Fig. 5 Trends in age-standardized mortalities of selected cancers by sex from 1983 to 2018 in Korea. (A) Men. (B) Women. Age standardization was based on Segi’s world standard population. a)Cancers of cervix uteri, corpus uteri, and unspecified parts of the uterus were combined (C53–C55), due to their unclear classifications in the past.
    Fig. 6 Five-year relative survival rates by stage at diagnosis and stage distribution of selected cancers by sex in Korea, 2014–2018. (A) Men. (B) Women. Staging according to the Surveillance, Epidemiology, and End Results (SEER) stage categories. For each cancer type, stage categories do not total 100% because sufficient information was not available to stage all cases. a)Includes the gallbladder and other/unspecified parts of the biliary tract.
    Fig. 7 Prevalent cases of common cancers by time since cancer diagnosis. Prevalent cases were defined as the number of cancer patients alive on January 1, 2019 among all cancer patients diagnosed between 1999 and 2018.

    Fig. 1

    Fig. 2

    Fig. 3

    Fig. 4

    Fig. 5

    Fig. 6

    Fig. 7

    Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2018

    Cancer incidence, mortality, and prevalence by sex in Korea, 2018

    Site/Type New cases Deaths Prevalent casesa)
    Both sexes Men Women Both sexes Men Women Both sexes Men Women
    All sites 243,837 128,757 115,080 79,153 48,898 30,255 2,005,520 881,057 1,124,463
    Lip, oral cavity, and pharynx 3,806 2,740 1,066 1,137 841 296 27,533 18,422 9,111
    Esophagus 2,698 2,449 249 1,435 1,314 121 11,238 10,055 1,183
    Stomach 29,279 19,865 9,414 7,746 5,083 2,663 304,265 201,278 102,987
    Colon and rectum 27,909 16,686 11,223 8,715 4,900 3,815 265,291 157,777 107,514
    Liverb) 15,736 11,728 4,008 10,611 7,790 2,821 71,774 53,903 17,871
    Gallbladderc) 7,179 3,840 3,339 4,871 2,504 2,367 24,013 12,408 11,605
    Pancreas 7,611 4,020 3,591 6,036 3,193 2,843 13,321 6,926 6,395
    Larynx 1,143 1,081 62 295 271 24 11,461 10,787 674
    Lungd) 28,628 19,524 9,104 17,852 13,188 4,664 93,600 56,954 36,646
    Breast 23,647 100 23,547 2,473 13 2,460 237,771 867 236,904
    Cervix uteri 3,500 - 3,500 845 - 845 57,104 - 57,104
    Corpus uteri 3,182 - 3,182 327 - 327 28,249 - 28,249
    Ovary 2,898 - 2,898 1,243 - 1,243 22,641 - 22,641
    Prostate 14,857 14,857 - 1,995 1,995 - 96,852 96,852 -
    Testis 335 335 - 17 17 - 3,747 3,747 -
    Kidney 5,456 3,806 1,650 989 672 317 46,358 31,302 15,056
    Bladder 4,577 3,650 927 1,400 1,055 345 37,722 30,734 6,988
    Brain and CNS 2,024 1,088 936 1,355 727 628 12,356 6,332 6,024
    Thyroid 28,651 6,727 21,924 372 109 263 432,932 77,440 355,492
    Hodgkin lymphoma 299 181 118 62 39 23 3,215 1,988 1,227
    Non-Hodgkin lymphoma 5,216 3,001 2,215 1,876 1,075 801 35,224 19,993 15,231
    Multiple myeloma 1,719 927 792 953 508 445 7,008 3,677 3,331
    Leukemia 3,494 2,037 1,457 1,848 1,081 767 23,782 13,250 10,532
    Other and ill-defined 19,993 10,115 9,878 4,700 2,523 2,177 138,063 66,365 71,698

    CNS, central nervous system.

    a)Limited-duration prevalent cases on January 1, 2018. These are patients who were diagnosed between January 1, 1999 and December 31, 2018, and who were alive on January 1, 2019. Multiple primary cancer cases were counted multiple times,

    b)Includes the liver and intrahepatic bile duct,

    c)Includes the gallbladder and other/unspecified parts of the biliary tract,

    d)Includes the lung and bronchus.

    Crude and age-standardized cancer incidence rates by sex in Korea, 2018

    Site/Type Crude incidence rates per 100,000 Age-standardized incidence rates per 100,000a)
    Both sexes Men Women Both sexes Men Women
    All sites 475.3 502.9 447.8 270.4 295.2 259.4
    Lip, oral cavity, and pharynx 7.4 10.7 4.1 4.3 6.3 2.4
    Esophagus 5.3 9.6 1.0 2.7 5.4 0.5
    Stomach 57.1 77.6 36.6 30.4 44.3 18.3
    Colon and rectum 54.4 65.2 43.7 28.4 37.4 20.6
    Liverb) 30.7 45.8 15.6 16.2 26.3 7.2
    Gallbladderc) 14.0 15.0 13.0 6.6 8.2 5.2
    Pancreas 14.8 15.7 14.0 7.4 8.8 6.3
    Larynx 2.2 4.2 0.2 1.2 2.4 0.1
    Lungd) 55.8 76.3 35.4 27.6 41.9 16.4
    Breast 46.1 0.4 91.6 29.1 0.2 57.9
    Cervix uteri 6.8 - 13.6 4.4 - 8.8
    Corpus uteri 6.2 - 12.4 3.9 - 7.7
    Ovary 5.6 - 11.3 3.6 - 7.1
    Prostate 29.0 58.0 - 14.3 31.9 -
    Testis 0.7 1.3 - 0.7 1.3 -
    Kidney 10.6 14.9 6.4 6.3 9.2 3.6
    Bladder 8.9 14.3 3.6 4.3 7.9 1.5
    Brain and CNS 3.9 4.2 3.6 3.0 3.3 2.7
    Thyroid 55.8 26.3 85.3 40.2 18.8 62.2
    Hodgkin lymphoma 0.6 0.7 0.5 0.5 0.6 0.4
    Non-Hodgkin lymphoma 10.2 11.7 8.6 6.5 8.0 5.0
    Multiple myeloma 3.4 3.6 3.1 1.7 2.0 1.4
    Leukemia 6.8 8.0 5.7 5.3 6.4 4.4
    Other and ill-defined 39.0 39.5 38.4 21.9 24.5 19.7

    CNS, central nervous system.

    a)Age-adjusted using Segi’s world standard population,

    b)Includes the liver and intrahepatic bile duct,

    c)Includes the gallbladder and other/unspecified parts of the biliary tract,

    d)Includes the lung and bronchus.

    The top 10 leading causes of death in Korea, 2018

    Rank Cause of death No. of deaths Percentage of all deaths Age-standardized death rate per 100,000a)
    All causes 298,777 100.0 268.3
    1 Cancer 79,153 26.5 73.3
    2 Heart disease 32,004 10.7 26.5
    3 Cerebrovascular disease 22,940 7.7 18.7
    4 Pneumonia 23,280 7.8 17.5
    5 Intentional self-harm (suicide) 13,670 4.6 18.2
    6 Diabetes mellitus 8,789 2.9 7.3
    7 Disease of liver 6,858 2.3 7.4
    8 Chronic lower respiratory diseases 6,608 2.2 5.0
    9 Hypertensive diseases 6,065 2.0 4.5
    10 Transport accidents 4,671 1.6 5.7
    Others 94,782 31.7 84.3

    Source: Mortality data, 2018, Statistics Korea [5].

    a)Age-adjusted using Segi’s world standard population.

    Crude and age-standardized cancer mortality rates by sex in Korea, 2018

    Site/Type Crude mortality rates per 100,000 Age-standardized mortality rates per 100,000a)
    Both sexes Men Women Both sexes Men Women
    All sites 154.3 191.0 117.7 73.3 105.3 49.5
    Lip, oral cavity, and pharynx 2.2 3.3 1.2 1.1 1.8 0.5
    Esophagus 2.8 5.1 0.5 1.3 2.8 0.2
    Stomach 15.1 19.9 10.4 7.1 11.0 4.1
    Colon and rectum 17.0 19.1 14.8 7.7 10.6 5.5
    Liverb) 20.7 30.4 11.0 10.2 17.0 4.4
    Gallbladderc) 9.5 9.8 9.2 4.2 5.2 3.4
    Pancreas 11.8 12.5 11.1 5.5 6.9 4.3
    Larynx 0.6 1.1 0.1 0.3 0.6 0.0
    Lungd) 34.8 51.5 18.1 15.7 27.5 7.0
    Breast 4.8 0.1 9.6 2.7 0.0 5.3
    Cervix uteri 1.6 - 3.3 0.9 - 1.7
    Corpus uteri 0.6 - 1.3 0.3 - 0.6
    Ovary 2.4 - 4.8 1.3 - 2.4
    Prostate 3.9 7.8 - 1.5 4.2 -
    Testis 0.0 0.1 - 0.0 0.1 -
    Kidney 1.9 2.6 1.2 0.9 1.5 0.5
    Bladder 2.7 4.1 1.3 1.1 2.2 0.4
    Brain and CNS 2.6 2.8 2.4 1.7 1.9 1.5
    Thyroid 0.7 0.4 1.0 0.3 0.2 0.4
    Hodgkin lymphoma 0.1 0.2 0.1 0.1 0.1 0.0
    Non-Hodgkin lymphoma 3.7 4.2 3.1 1.8 2.4 1.3
    Multiple myeloma 1.9 2.0 1.7 0.8 1.1 0.7
    Leukemia 3.6 4.2 3.0 2.1 2.7 1.7
    Other and ill-defined 9.2 9.9 8.5 4.5 5.7 3.6

    CNS, central nervous system.

    a)Age-adjusted using Segi’s world standard population,

    b)Includes the liver and intrahepatic bile duct,

    c)Includes the gallbladder and other/unspecified parts of the biliary tract,

    d)Includes the lung and bronchus.

    Trends in cancer incidence and mortality rates from 1999 to 2018 in Korea, both sexes

    Site/Type Incidence Mortality
    1999 2018 Trend 1 Trend 2 Trend 3 1999 2018 Trend 1 Trend 2 Trend 3
    Years APC Years APC Years APC Years APC Years APC Years APC
    All sites 212.0 270.4 1999–2012 3.3a) 2012–2015 −5.4a) 2015–2018 1.0 114.3 73.3 1999–2002 1.0 2002–2014 −2.7a) 2014–2018 −3.7a)
    Lip, oral cavity, and pharynx 3.6 4.3 1999–2018 0.7a) - - - - 1.1 1.1 1999–2018 −1.9a) - - - -
    Esophagus 4.1 2.7 1999–2018 −2.2a) - - - - 3.1 1.3 1999–2018 −4.4a) - - - -
    Stomach 43.6 30.4 1999–2011 −0.2 2011–2018 −4.6a) - - 23.8 7.1 1999–2002 −2.6a) 2002–2010 −6.2a) 2010–2018 −7.4a)
    Colon and rectum 20.6 28.4 1999–2006 7.2a) 2006–2011 3.1a) 2011–2018 −4.4a) 7.7 7.7 1999–2003 6.4a) 2003–2012 −0.4 2012–2018 −3.8a)
    Liverb) 27.9 16.2 1999–2010 −1.7a) 2010–2018 −4.3a) - - 20.4 10.2 1999–2002 0.7 2002–2014 −3.6a) 2014–2018 −6.4a)
    Gallbladderc) 6.5 6.6 1999–2004 1.4 2004–2018 −0.3a) - - 5.2 4.2 1999–2001 7.6 2001–2014 −2.8a) 2014–2018 0.5
    Pancreas 5.6 7.4 1999–2018 1.5a) - - - - 5.4 5.5 1999–2018 0.2 - - - -
    Larynx 2.4 1.2 1999–2018 −3.6a) - - - - 1.6 0.3 1999–2005 −8.0a) 2005–2008 −15.4a) 2008–2018 −7.1a)
    Lungd) 28.5 27.6 1999–2011 0.1 2011–2015 −1.4a) 2015–2018 0.7 22.4 15.7 1999–2001 3.7 2001–2014 −1.9a) 2014–2018 −4.3a)
    Breast 11.0 29.1 1999–2007 6.4a) 2007–2018 4.4a) - - 2.2 2.7 1999–2016 1.4a) 2016–2018 −2.7 - -
    Cervix uteri 8.6 4.4 1999–2001 −1.0 2001–2007 −5.4a) 2007–2018 −2.8a) 1.4 0.9 1999–2003 10.0a) 2003–2008 −7.0a) 2008–2018 −4.2a)
    Corpus uteri 1.4 3.9 1999–2018 5.1a) - - - - 0.1 0.3 1999–2003 35.9a) 2003–2018 2.4a) - -
    Ovary 2.7 3.6 1999–2018 1.7a) - - - - 0.9 1.3 1999–2018 0.7a) - - - -
    Prostate 3.1 14.3 1999–2009 14.9a) 2009–2015 0.6 2015–2018 6.8a) 0.9 1.5 1999–2002 15.0a) 2002–2011 1.7a) 2011–2018 −1.5a)
    Testis 0.3 0.7 1999–2018 4.8a) - - - - 0.0 0.0 1999–2018 −2.4a) - - - -
    Kidney 3.0 6.3 1999–2009 6.4a) 2009–2018 2.0a) - - 1.1 0.9 1999–2018 −0.4 - - - -
    Bladder 4.7 4.3 1999–2004 1.9a) 2004–2018 −1.1a) - - 1.3 1.1 1999–2001 10.5 2001–2018 −1.9a) - -
    Brain and CNS 2.9 3.0 1999–2018 0.2 - - - - 1.9 1.7 1999–2002 6.3a) 2002–2008 −3.5a) 2008–2018 −0.9a)
    Thyroid 6.5 40.2 1999–2011 21.7a) 2011–2018 −9.3a) - - 0.4 0.3 1999–2003 7.5a) 2003–2018 −4.5a) - -
    Hodgkin lymphoma 0.3 0.5 1999–2018 3.6a) - - - - 0.0 0.1 1999–2004 23.0a) 2004–2018 −1.7 - -
    Non-Hodgkin lymphoma 4.3 6.5 1999–2018 2.3a) - - - - 2.1 1.8 1999–2018 −1.0a) - - - -
    Multiple myeloma 1.0 1.7 1999–2012 3.7a) 2012–2018 1.0 - - 0.6 0.8 1999–2003 12.6a) 2003–2016 1.0 2016–2018 −7.6
    Leukemia 4.7 5.3 1999–2018 0.9a) - - - - 2.9 2.1 1999–2018 −1.8a) - - - -
    Other and ill-defined 15.0 21.9 1999–2001 −0.9 2001–2007 3.6a) 2007–2018 1.8a) 7.8 4.5 1999–2018 −2.8a) - - - -

    APC was calculated using age-standardized incidence data based on Segi’s world standard population. APC, annual percentage change; CNS, central nervous system.

    a)Significantly different from zero (p < 0.05),

    b)Includes the liver and intrahepatic bile duct,

    c)Includes the gallbladder and other/unspecified parts of the biliary tract,

    d)Includes the lung and bronchus.

    Trends in the 5-year relative survival rates (%) by sex and year of diagnosis from 1993 to 2018 in Korea

    Site/Type Both sexes Men Women
    1993–1995 1996–2000 2001–2005 2006–2010 2011–2015 2014–2018 Changea) 1993–1995 1996–2000 2001–2005 2006–2010 2011–2015 2014–2018 Changea) 1993–1995 1996–2000 2001–2005 2006–2010 2011–2015 2014–2018 Changea)
    All sites 42.9 45.1 54.1 65.5 70.7 70.3 27.4 33.2 36.3 45.6 56.8 63.1 63.8 30.6 55.1 56.4 64.3 74.4 78.3 77.1 22.0
    All sites excluding thyroid 41.2 43.3 50.8 59.0 64.2 65.7 24.5 32.7 35.8 44.7 54.6 60.3 61.6 28.9 52.6 53.5 59.1 65.0 69.3 70.8 18.2
    Lip, oral cavity, and pharynx 42.2 47.4 54.5 61.1 65.4 68.0 25.8 36.6 41.7 49.6 56.9 61.8 65.0 28.4 59.4 64.5 68.1 72.1 74.5 75.4 16.0
    Esophagus 14.0 15.7 21.5 30.0 36.6 39.5 25.5 13.0 14.8 20.8 29.3 36.2 38.9 25.9 25.0 25.9 29.8 37.2 40.1 44.9 19.9
    Stomach 43.8 47.3 58.0 68.4 75.9 77.0 33.2 43.9 47.6 58.7 69.1 76.8 77.8 33.9 43.7 46.8 56.6 67.0 74.0 75.2 31.5
    Colon and rectum 56.2 58.8 66.9 73.9 76.1 74.3 18.1 56.6 59.8 68.8 75.8 77.8 75.6 19.0 55.7 57.7 64.5 71.1 73.6 72.3 16.6
    Liverb) 11.8 14.1 20.5 28.3 34.4 37.0 25.2 10.8 13.8 20.4 28.2 34.9 37.8 27.0 15.0 15.1 20.9 28.3 32.8 34.7 19.7
    Gallbladderc) 18.7 20.7 23.1 26.9 28.7 28.8 10.1 18.0 21.1 23.4 27.8 29.4 29.8 11.8 19.3 20.3 22.7 26.0 28.0 27.8 8.5
    Pancreas 10.6 8.7 8.4 8.5 10.8 12.6 2.0 10.0 8.3 8.4 8.3 10.2 11.9 1.9 11.5 9.2 8.4 8.8 11.4 13.2 1.7
    Larynx 61.6 63.3 66.5 73.2 75.1 78.6 17.0 62.1 63.7 67.1 73.5 75.5 78.9 16.8 56.3 58.9 58.7 68.0 68.8 74.1 17.8
    Lungd) 12.5 13.6 16.6 20.3 27.5 32.4 19.9 11.6 12.4 15.3 18.0 23.3 27.0 15.4 15.8 17.5 20.2 26.0 37.3 44.3 28.5
    Breast 79.2 83.6 88.7 91.2 92.8 93.3 14.1 77.1 84.3 87.5 89.9 90.5 91.9 14.8 79.3 83.6 88.7 91.2 92.8 93.3 14.0
    Cervix uteri 78.3 80.3 81.5 80.7 80.3 80.5 2.2 - - - - - - - 78.3 80.3 81.5 80.7 80.3 80.5 2.2
    Corpus uteri 82.9 82.0 84.7 86.5 87.8 88.6 5.7 - - - - - - - 82.9 82.0 84.7 86.5 87.8 88.6 5.7
    Ovary 60.1 59.4 61.7 61.2 64.7 65.2 5.1 - - - - - - - 60.1 59.4 61.7 61.2 64.7 65.2 5.1
    Prostate 59.2 69.3 81.0 92.0 94.2 94.4 35.2 59.2 69.3 81.0 92.0 94.2 94.4 35.2 - - - - - - -
    Testis 87.4 90.4 90.7 93.1 94.8 95.1 7.7 87.4 90.4 90.7 93.1 94.8 95.1 7.7 - - - - - - -
    Kidney 64.2 67.0 73.7 78.6 82.6 84.1 19.9 63.4 65.3 73.1 78.5 82.2 84.3 20.9 65.8 70.3 74.9 79.0 83.4 83.7 17.9
    Bladder 70.7 73.6 76.0 77.2 76.4 76.6 5.9 71.6 75.1 77.8 79.2 78.3 78.6 7.0 67.2 67.2 69.1 69.1 68.2 68.2 1.0
    Brain and CNS 40.4 39.9 41.0 42.9 41.6 40.9 0.5 39.1 38.6 40.3 41.3 40.1 39.8 0.7 42.2 41.4 41.8 44.6 43.2 42.2 -
    Thyroid 94.5 95.0 98.4 100.0 100.2 100.0 5.5 87.8 89.7 96.0 100.2 100.6 100.4 12.6 95.7 96.0 98.7 99.9 100.1 99.9 4.2
    Hodgkin lymphoma 70.1 71.9 76.7 81.1 82.3 84.5 14.4 69.2 69.3 74.7 80.8 81.8 81.8 12.6 71.5 77.3 80.7 81.6 83.2 88.8 17.3
    Non-Hodgkin lymphoma 48.3 51.1 56.0 59.4 62.8 64.0 15.7 46.8 49.6 55.0 59.2 62.8 64.8 18.0 50.7 53.3 57.5 59.7 62.8 62.9 12.2
    Multiple myeloma 23.5 21.1 29.7 35.0 41.5 46.6 23.1 23.0 19.2 29.9 35.2 41.0 46.9 23.9 24.1 23.3 29.5 34.7 42.0 46.4 22.3
    Leukemia 27.5 34.3 42.0 47.7 51.9 53.4 25.9 27.3 33.3 41.8 46.9 52.2 53.4 26.1 27.8 35.5 42.2 48.7 51.6 53.6 25.8
    Other and ill-defined 44.5 48.3 57.8 67.6 72.7 74.8 30.3 39.6 44.7 54.0 63.8 69.3 71.7 32.1 50.1 52.6 62.0 71.6 76.1 77.9 27.8

    CNS, central nervous system.

    a)Absolute percentage change in 5-year relative survival from 1993 to 1995 and 2014 to 2018,

    b)Includes the liver and intrahepatic bile duct,

    c)Includes the gallbladder and other/unspecified parts of the biliary tract,

    d)Includes the lung and bronchus.

    Crude and age-standardized rates of cancer prevalence by sex on January 1, 2019 in Korea

    Site/Type Crude prevalence rates per 100,000a) Age-standardized prevalence rates per 100,000b)
    Both sexes Men Women Both sexes Men Women
    All sites 3,909.3 3,441.4 4,375.5 2,216.8 2,018.5 2,499.4
    Lip, oral cavity, and pharynx 53.7 72.0 35.5 30.9 43.0 20.2
    Esophagus 21.9 39.3 4.6 11.0 21.7 2.2
    Stomach 593.1 786.2 400.7 304.6 440.6 191.7
    Colon and rectum 517.1 616.3 418.4 262.5 347.0 193.7
    Liverc) 139.9 210.5 69.5 76.7 122.3 35.3
    Gallbladderd) 46.8 48.5 45.2 22.6 26.7 19.4
    Pancreas 26.0 27.1 24.9 14.1 15.7 12.8
    Larynx 22.3 42.1 2.6 11.1 23.3 1.2
    Lunge) 182.5 222.5 142.6 92.8 123.6 68.9
    Breast 463.5 3.4 921.8 273.9 1.9 539.4
    Cervix uteri 111.3 - 222.2 64.6 - 126.4
    Corpus uteri 55.1 - 109.9 32.5 - 64.1
    Ovary 44.1 - 88.1 28.4 - 56.4
    Prostate 188.8 378.3 - 85.7 200.7 -
    Testis 7.3 14.6 - 6.5 12.8 -
    Kidney 90.4 122.3 58.6 52.0 73.9 32.2
    Bladder 73.5 120.0 27.2 35.2 66.1 11.3
    Brain and CNS 24.1 24.7 23.4 19.9 21.1 18.7
    Thyroid 843.9 302.5 1,383.3 536.4 196.8 874.0
    Hodgkin lymphoma 6.3 7.8 4.8 5.1 6.1 4.0
    Non-Hodgkin lymphoma 68.7 78.1 59.3 45.7 54.8 37.2
    Multiple myeloma 13.7 14.4 13.0 7.2 8.1 6.3
    Leukemia 46.4 51.8 41.0 41.5 46.6 36.4
    Other and ill-defined 269.1 259.2 279.0 155.8 165.8 147.6

    CNS, central nervous system.

    a)Crude prevalence rate: number of prevalent cases divided by the corresponding person-years of observation. Prevalent cases were defined as patients who were diagnosed between January 1, 1999 and December 31, 2018, and who were alive on January 1, 2019. Multiple primary cancer cases were counted multiple times,

    b)Age-adjusted using Segi’s world standard population,

    c)Includes the liver and intrahepatic bile duct,

    d)Includes the gallbladder and other/unspecified parts of the biliary tract,

    e)Includes the lung and bronchus.
    Table 1 Cancer incidence, mortality, and prevalence by sex in Korea, 2018

    CNS, central nervous system.

    Limited-duration prevalent cases on January 1, 2018. These are patients who were diagnosed between January 1, 1999 and December 31, 2018, and who were alive on January 1, 2019. Multiple primary cancer cases were counted multiple times,

    Includes the liver and intrahepatic bile duct,

    Includes the gallbladder and other/unspecified parts of the biliary tract,

    Includes the lung and bronchus.

    Table 2 Crude and age-standardized cancer incidence rates by sex in Korea, 2018

    CNS, central nervous system.

    Age-adjusted using Segi’s world standard population,

    Includes the liver and intrahepatic bile duct,

    Includes the gallbladder and other/unspecified parts of the biliary tract,

    Includes the lung and bronchus.

    Table 3 The top 10 leading causes of death in Korea, 2018

    Source: Mortality data, 2018, Statistics Korea [5].

    Age-adjusted using Segi’s world standard population.

    Table 4 Crude and age-standardized cancer mortality rates by sex in Korea, 2018

    CNS, central nervous system.

    Age-adjusted using Segi’s world standard population,

    Includes the liver and intrahepatic bile duct,

    Includes the gallbladder and other/unspecified parts of the biliary tract,

    Includes the lung and bronchus.

    Table 5 Trends in cancer incidence and mortality rates from 1999 to 2018 in Korea, both sexes

    APC was calculated using age-standardized incidence data based on Segi’s world standard population. APC, annual percentage change; CNS, central nervous system.

    Significantly different from zero (p < 0.05),

    Includes the liver and intrahepatic bile duct,

    Includes the gallbladder and other/unspecified parts of the biliary tract,

    Includes the lung and bronchus.

    Table 6 Trends in the 5-year relative survival rates (%) by sex and year of diagnosis from 1993 to 2018 in Korea

    CNS, central nervous system.

    Absolute percentage change in 5-year relative survival from 1993 to 1995 and 2014 to 2018,

    Includes the liver and intrahepatic bile duct,

    Includes the gallbladder and other/unspecified parts of the biliary tract,

    Includes the lung and bronchus.

    Table 7 Crude and age-standardized rates of cancer prevalence by sex on January 1, 2019 in Korea

    CNS, central nervous system.

    Crude prevalence rate: number of prevalent cases divided by the corresponding person-years of observation. Prevalent cases were defined as patients who were diagnosed between January 1, 1999 and December 31, 2018, and who were alive on January 1, 2019. Multiple primary cancer cases were counted multiple times,

    Age-adjusted using Segi’s world standard population,

    Includes the liver and intrahepatic bile duct,

    Includes the gallbladder and other/unspecified parts of the biliary tract,

    Includes the lung and bronchus.

    Table 1

    Table 2

    Table 3

    Table 4

    Table 5

    Table 6

    Table 7

    Cancer Res Treat : Cancer Research and Treatment
    © Korean Cancer Association.
    Close layer
    TOP